Fact-checked by Grok 2 weeks ago

SNP genotyping

Single nucleotide polymorphism (SNP) genotyping is the process of determining the specific alleles present at positions in an individual's DNA where single nucleotide polymorphisms—variations involving a single nucleotide base—occur. SNPs represent the most common form of genetic variation among people, with each polymorphism consisting of a difference in a single DNA building block, such as replacing cytosine (C) with thymine (T), and occurring approximately once every 1,000 nucleotides on average. Over 1.2 billion SNPs have been identified across human populations (as of 2025), though only a subset are common (present in at least 1% of individuals), and they account for the majority of sequence differences between any two unrelated genomes. This genotyping technique enables the precise identification of an individual's genotype—whether homozygous or heterozygous—at these sites, serving as a foundational tool in genomics. The importance of SNP genotyping stems from its role in linking genetic variations to phenotypic traits, disease risks, and therapeutic responses. SNPs act as biological markers to locate genes associated with complex diseases such as heart disease, , and cancer, facilitating genome-wide association studies (GWAS) that scan millions of SNPs to identify susceptibility loci. In , genotyping helps predict individual responses to drugs by revealing variants that influence or efficacy, thereby supporting approaches. Additionally, SNPs are used to trace ancestry, study , and map inheritance patterns within families, providing insights into and . A variety of technologies underpin SNP genotyping, broadly categorized by their principles of allele discrimination and detection. Common methods include PCR-based assays, which use allele-specific fluorescent probes during to quantify signals in ; microarray platforms, such as Illumina bead arrays, that hybridize target DNA to immobilized probes for high-throughput analysis of up to 2 million SNPs simultaneously; and next-generation sequencing (NGS), which generates comprehensive sequence data to call both known and novel SNPs through alignment to reference genomes. These approaches have evolved for greater accuracy, scalability, and cost-efficiency, with NGS enabling variant discovery while PCR methods offer targeted, rapid genotyping for clinical applications. Advances continue to integrate multi-sample analysis and probabilistic modeling to enhance call confidence, achieving accuracies exceeding 99% in well-designed studies.

Fundamentals

Single Nucleotide Polymorphisms

Single nucleotide polymorphisms (SNPs) are defined as single base-pair variations in the DNA sequence where one nucleotide is substituted for another, occurring at a frequency of at least 1% in a population, distinguishing them from rare mutations. These variations can involve any of the four nucleotide bases (adenine, thymine, cytosine, or guanine) and are typically biallelic, meaning they result in two possible alleles at a given position. SNPs represent the most common form of genetic variation in the human genome, serving as stable markers due to their low mutation rates compared to other variant types. SNPs are classified based on their location and functional impact relative to genes. In coding regions, they are categorized as synonymous, which do not alter the sequence due to the degeneracy of the , or non-synonymous, which change the and may affect protein function. Exonic SNPs occur within exons, while intronic SNPs are found in introns; additionally, SNPs can reside in regulatory elements such as promoters, potentially influencing by altering binding sites. Most SNPs (~90-95%) are located in non-coding regions, where their density is higher than in coding sequences, reflecting less selective pressure on these areas. In the , approximately 10 million common SNPs (with >1%) have been identified, though comprehensive catalogs like the report over 84 million total SNPs across diverse populations. Evolutionarily, SNPs act as key indicators of , capturing historical population bottlenecks, migrations, and events that shape ancestry patterns. For cataloging, the dbSNP database assigns unique reference SNP identifiers (rsIDs), such as rs12345, to track and annotate these variants across studies and genomes.

Importance of Genotyping

Single nucleotide polymorphisms () play a pivotal role in disease studies by identifying genetic variants linked to complex traits and disorders. For instance, the rs7903146 SNP in the TCF7L2 gene has been strongly associated with an increased of , with carriers of the showing up to a 1.4-fold higher susceptibility in large-scale genome-wide studies (GWAS). Similarly, SNPs in the 8q24 region, such as rs6983267, confer elevated for multiple cancers, including and colorectal types, where the is present in approximately 50% of Europeans and contributes to tumor initiation through regulatory effects on nearby oncogenes like . These have enabled the development of polygenic scores that predict disease susceptibility with improved accuracy, guiding preventive strategies in clinical settings. In , SNP genotyping facilitates by revealing how genetic variants influence drug response and . A prominent example is the , where poor metabolizer alleles (e.g., *4) impair the conversion of to its , resulting in reduced efficacy and up to 50% of patients experiencing inadequate pain relief. Conversely, ultrarapid metabolizers with duplicated functional alleles can produce excessive , leading to toxicity risks such as respiratory depression, as demonstrated in clinical cases where genotyping predicted adverse outcomes. This has prompted regulatory guidelines, including FDA warnings, to avoid in poor metabolizers, thereby enhancing treatment safety and efficacy across diverse populations. SNP genotyping is essential in for tracing ancestry, kinship, and . Ancestry informative markers (AIMs), such as those identified through of SNP data, allow differentiation of continental origins with over 99% accuracy using as few as 3,000 SNPs, enabling and migration history reconstruction. In evolutionary studies, dense SNP panels have mapped patterns, revealing continuous genetic gradients across that reflect ancient dispersals from around 60,000 years ago. These applications extend to assessments, where SNPs quantify in to inform priorities. Beyond human applications, SNP genotyping drives advancements in and . In programs, SNPs enable genomic selection in crops like and livestock such as , accelerating improvement for yield and disease resistance by 20-50% compared to traditional methods, with over 50,000 SNPs routinely used in commercial panels. Evolutionarily, SNPs illuminate and in non-human species, such as tracking Neanderthal in modern humans via analysis. Economically, the global SNP genotyping market, fueled by these applications, is estimated at approximately USD 30.01 billion in 2025.

Sample Preparation and Amplification

DNA Isolation

DNA isolation is the foundational step in SNP genotyping workflows, providing high-quality genomic DNA free from contaminants that could interfere with downstream enzymatic reactions such as PCR amplification. This process involves lysing cells to release DNA, followed by purification to remove proteins, lipids, and other impurities, ensuring sufficient yield and integrity for reliable genotyping. Common challenges include achieving adequate DNA quantity from limited samples and maintaining purity to prevent inhibition of amplification enzymes. Traditional phenol-chloroform extraction remains a widely used method for isolating high-molecular-weight DNA, particularly from blood and tissue samples. In this technique, cells are lysed with detergents and , followed by using phenol-chloroform-isoamyl alcohol to partition DNA into the aqueous phase, with subsequent for recovery. It offers high yields of intact DNA suitable for but requires careful handling due to the hazardous nature of the reagents. Silica-based column purification, exemplified by kits like QIAGEN's DNeasy, provides a safer alternative by binding DNA to a silica under chaotropic salt conditions (e.g., guanidine ), allowing wash steps to remove contaminants before elution in low-salt buffer. These kits are favored for their speed and consistency in applications, yielding DNA of sufficient length (>10 kb) for PCR-based assays. Magnetic bead-based purification has gained prominence for its compatibility with automation in high-throughput genotyping projects. DNA binds to carboxylated magnetic particles in the presence of chaotropic salts, enabling , washing, and elution without . Systems like those using AMPure XP beads or similar formulations efficiently recover DNA fragments across a broad size range, minimizing shearing and supporting multiplexed SNP analysis. DNA isolation methods must be adapted to diverse sample types, including , , fresh , and formalin-fixed paraffin-embedded (FFPE) tissues, each presenting unique challenges in yield and purity. is the most common source, where are preferentially lysed to yield typically 4-10 μg of DNA from 200 μL of using silica or magnetic methods. provides a non-invasive alternative but often requires stabilization buffers to prevent degradation, yielding typically 10-60 μg per mL, though highly variable, with potential carryover. samples demand mechanical homogenization or enzymatic digestion prior to extraction, while FFPE samples necessitate deparaffinization and cross-link reversal to recover fragmented DNA (typically 200 bp-5 kb), suitable for targeted but with lower yields (0.1-5 μg per section). Quality assessment is critical, with spectrophotometric measurement of the A260/A280 ratio serving as a primary indicator of purity; a value of approximately 1.8 signifies minimal protein contamination, essential for efficient PCR in genotyping. Contaminants such as proteins, salts, or residual phenols can inhibit Taq polymerase, leading to failed amplifications, while humic acids or heme from certain samples may require additional cleanup. Fluorometric quantification (e.g., PicoGreen) complements absorbance readings to accurately determine double-stranded DNA concentration, ensuring at least 10-50 ng/μL for standard genotyping protocols. For large-scale SNP genotyping studies involving thousands of samples, automated systems like the Thermo Scientific KingFisher enhance efficiency and reproducibility. These instruments use magnetic rod or particle separation technology to process up to 96 samples per run, integrating lysis, binding, and elution in under 30 minutes with minimal hands-on time. Such automation reduces variability and supports integration with downstream PCR workflows, where the isolated DNA serves directly as template material.

PCR Amplification Techniques

Polymerase chain reaction (PCR) is a fundamental technique for amplifying specific DNA regions containing single nucleotide polymorphisms (SNPs) prior to genotyping detection, enabling the enrichment of target sequences from genomic DNA samples. Standard PCR relies on key components including thermostable Taq DNA polymerase, deoxynucleotide triphosphates (dNTPs), and oligonucleotide primers flanking the SNP locus, typically in a reaction buffer optimized for enzymatic activity. The process involves thermal cycling: denaturation at approximately 95°C to separate DNA strands, annealing at 50–60°C for primer binding, and extension at 72°C where Taq polymerase synthesizes new strands, repeated for 30–40 cycles to achieve exponential amplification. These steps, performed in a thermal cycler, generate amplicons of defined length (often 100–500 base pairs) suitable for downstream SNP analysis. Variants of standard address limitations in specificity and throughput for applications. Hot-start PCR incorporates modified that activates only at high temperatures (above 70°C), minimizing non-specific primer annealing and primer-dimer formation during setup, which is particularly beneficial for low-abundance targets in complex genomes. Multiplex PCR extends this by using multiple primer pairs in a single reaction to amplify several loci simultaneously, reducing time and reagent costs; for example, it has been applied to genotype up to 50 SNPs in crop like grapevines using optimized buffer conditions. Quantitative evaluation of performance is essential for reliable amplification, with cycle threshold () values indicating the cycle at which (in formats) exceeds a , typically ranging from 15–35 for efficient reactions. (E), calculated from standard curves as E = 10^{-1/\text{slope}}, should approach 2.0 (100%) for ideal doubling per cycle, where the slope derives from plotting against log template concentration; deviations below 1.8 (90%) signal issues like inhibitor presence or suboptimal primers. SNP-specific challenges in PCR primarily stem from primer design, as mismatches at the SNP site or nearby variants can introduce bias, leading to preferential amplification of one over another. To mitigate this, primers are positioned to avoid the SNP locus, with thermodynamic optimization ensuring similar melting temperatures (Tm ~60°C) and minimal secondary structures; tools like FastPCR aid in selecting sequences that enhance specificity without 3'-end mismatches. Post-2000 advances integrated real-time with SNP amplification, allowing in situ detection via fluorescent probes during cycling, which improved sensitivity for low-frequency variants and enabled allelic discrimination in multiplex formats.

Hybridization-Based Methods

Allele-Specific Hybridization

Allele-specific hybridization (ASH) exploits the differential stability of DNA duplexes formed by oligonucleotide probes designed to match one allele of a single nucleotide polymorphism (SNP) perfectly while introducing a mismatch with the alternative allele. This mismatch, typically positioned near the center of the probe, imposes a thermodynamic penalty that destabilizes the hybrid, enabling discrimination between alleles through variations in hybridization efficiency or melting temperature. The method's core principle relies on the subtle energetic differences caused by the single-base mismatch, which can be amplified under controlled stringency conditions to achieve reliable SNP detection without enzymatic steps. A key variant of ASH is dynamic allele-specific hybridization (DASH), which monitors hybridization kinetics in real-time by incrementally raising the temperature of the reaction mixture containing biotinylated PCR-amplified target DNA immobilized on a solid support and fluorophore-labeled allele-specific probes. In DASH, the melting temperature (Tm) of the perfectly matched probe-target duplex is higher than that of the mismatched one, producing distinct fluorescence decay curves that allow unambiguous genotyping; for instance, homozygous samples show a single sharp transition, while heterozygotes exhibit two. This temperature-controlled approach enhances specificity by exploiting the full dynamic range of duplex stability, making it suitable for both low- and medium-throughput applications. The specificity of ASH probes is modulated by probe length, generally 15-25 to optimize affinity while maintaining mismatch discrimination; , which influences overall duplex Tm and mismatch penalty; and hybridization concentrations, where elevated levels (e.g., 0.5-1 M NaCl) stabilize hybrids and necessitate higher temperatures for stringency. Shorter probes with balanced (40-60%) often yield the best discrimination, as excessive length or high can mask the mismatch effect, while low increases stringency but risks reducing overall signal. Detection in , particularly , frequently incorporates fluorescence resonance energy transfer () for sensitive, real-time readout, where a donor on the probe transfers energy to an acceptor upon stable hybridization, with signal loss indicating during . Improved configurations, such as iFRET, further refine this by using asymmetric labeling to minimize background and enhance curve resolution for accurate allele calling. ASH emerged in the early as a foundational technique for low-throughput SNP genotyping, with initial implementations using high-affinity probes like peptide nucleic acids (PNAs) to achieve single-base discrimination in dot-blot formats. These early assays laid the groundwork for subsequent hybridization-based platforms, including adaptations for scaled analysis.

Molecular Beacons

Molecular beacons are hairpin-shaped probes designed for the detection of specific sequences, including single nucleotide polymorphisms (SNPs), through fluorescence-based signaling. Developed in the late 1990s by Sanjay and Fred Russell Kramer, these probes consist of a loop region containing the target-complementary sequence flanked by a stem formed by complementary self-hybridizing arms; one arm end bears a , while the other has a quencher molecule that suppresses in the closed conformation. Upon binding to a complementary target sequence, the structure opens, separating the and quencher, which restores emission; a mismatch at the site destabilizes the probe-target due to reduced binding , minimizing signal generation and enabling discrimination. This mechanism relies on resonance energy transfer () for quenching in the intact , with typical quenching efficiencies ranging from 85% to 97%, though variations can occur depending on the fluorophore-quencher pair. In SNP genotyping, molecular beacons are integrated into (PCR) assays to monitor amplification and allele-specific hybridization in a homogeneous format, allowing simultaneous detection of multiple SNPs through probes with distinct fluorophores. For instance, they enable reliable genotyping of SNPs in genes like those associated with by distinguishing perfect matches from single-base mismatches during thermal cycling. Key advantages include the elimination of washing steps required in heterogeneous assays, facilitating high-throughput and real-time analysis, as well as enhanced specificity for single-base differences compared to linear probes like those in assays. However, limitations arise from incomplete , which can elevate background , and potential unintended self-hybridization or stem-loop instability that may affect probe performance under varying ionic conditions.

SNP Microarrays

SNP microarrays are high-throughput platforms that enable the simultaneous genotyping of hundreds of thousands to millions of single nucleotide polymorphisms (SNPs) by hybridizing fragmented genomic DNA to immobilized probes on a solid surface. These arrays facilitate genome-wide association studies and large-scale genetic analyses by providing dense coverage of genetic variation across the human genome. Developed in the early 2000s, SNP microarrays have evolved from targeted panels to comprehensive whole-genome solutions, leveraging advances in probe design and signal detection to achieve high accuracy and reproducibility. Key commercial platforms include the GeneChip and the Illumina BeadChip systems. The GeneChip employs a ligation-mediated approach in , where genomic DNA is first digested with restriction enzymes to generate fragments, followed by adaptor to enable amplification and labeling of the targets. These labeled fragments then hybridize to an array of probes tiled across the , with each represented by multiple perfect match (PM) probes that fully complement one and mismatch (MM) probes that differ by a single central base to reduce non-specific binding. After hybridization and washing, the array is scanned using a to measure intensities from bound targets. In contrast, the Illumina BeadChip utilizes an allele-specific extension method integrated into the Infinium assay. Genomic DNA is whole-genome amplified without locus-specific PCR, fragmented enzymatically, and hybridized to beads attached to a substrate, where each bead type carries a locus-specific 50-mer oligo probe ending one base before the SNP site. During a single-base extension step, DNA polymerase incorporates a fluorescently labeled nucleotide specific to the allele at the SNP position, followed by staining and scanning to capture red (for one allele) and green (for the other) channel intensities. This process supports multi-sample processing on BeadChips holding up to 12 or 24 samples per array. Both platforms output raw fluorescence intensities that are processed to generate calls. For arrays, intensities from PM and MM probes are contrasted to compute relative signals (e.g., , , ), while Illumina data yield normalized intensity ratios (often denoted as θ or B-allele frequency) from the two color channels to cluster samples into homozygous ( or ) or heterozygous () . Advanced algorithms, such as Birdseed for or GenomeStudio clustering for Illumina, refine these calls by modeling expected intensity distributions. Modern SNP microarrays interrogate over 1 million SNPs per sample, enabling near-complete coverage of common genetic variants. Early first-generation arrays in the 2000s, such as the 10K Mapping Array (2005) and Illumina Human-1 (100K SNPs), focused on candidate regions but rapidly scaled to whole-genome coverage with the Genome-Wide Human SNP Array 6.0 (906K SNPs, 2007) and Illumina Human1M-Duo (1.2 million SNPs). These advances have supported population-scale genotyping projects, with call rates exceeding 99% and accuracy comparable to for validated SNPs. Data analysis involves to correct for technical biases like dye effects or variations. For Illumina BeadChips, (QN) aligns intensity distributions across samples and loci, often enhanced with thresholding (tQN) to stabilize estimates and improve copy number and allelic ratio accuracy by 15-26% in standard deviation reduction. data typically use robust multi-array average (RMA)-like methods, incorporating background correction, of probes, and summarization via median polish to generate reliable relative allele difference () scores for . These steps ensure robust downstream applications, such as imputation and testing. Cost reductions have made SNP microarrays accessible for large cohorts, dropping from thousands of dollars per sample in the early 2000s to under $100 by 2025 through , automated workflows, and applications. This affordability, combined with high throughput (e.g., processing 96-384 samples simultaneously), has democratized genome-wide for research and clinical use.

Enzyme-Based Methods

Restriction Fragment Length Polymorphism

Restriction Fragment Length Polymorphism (RFLP) is an enzyme-based method for SNP genotyping that exploits variations in DNA sequence to produce distinguishable restriction fragments. A single nucleotide polymorphism can create or abolish a recognition site for a specific restriction endonuclease, resulting in different patterns of DNA fragments after enzymatic digestion. This technique relies on the precise cutting of DNA at these sites, where the presence of one allele allows cleavage while the other does not, leading to fragments of varying lengths that can be separated and detected. The protocol for RFLP-based SNP genotyping typically begins with PCR amplification of the genomic region flanking the SNP to generate sufficient target DNA. The amplified product is then incubated with a whose recognition sequence is allele-specific, such as HaeIII for SNPs that introduce or remove its GGCC site. Following digestion, the resulting fragments are separated by size using or , allowing visualization of allele-specific band patterns. For detection, fragments are commonly stained with and imaged under ultraviolet light, though fluorescent labeling can enhance sensitivity in automated systems. Despite its simplicity and low cost, RFLP has notable limitations for SNP genotyping. It is only feasible for the subset of SNPs that alter sites, excluding the majority of polymorphisms and requiring careful enzyme selection. Additionally, the method is labor-intensive, involving multiple manual steps like and , which limits its throughput compared to modern high-density approaches. Historically, RFLP emerged as one of the earliest techniques in the , predating and enabling the first maps through polymorphic markers. Seminal work by Botstein et al. in 1980 proposed using RFLPs to construct a map, laying the foundation for positional and disease gene identification. With the advent of in the mid-, PCR-RFLP became a standard for targeted analysis, though it has largely been supplanted by more scalable methods.

Allele-Specific PCR

Allele-specific PCR (AS-PCR) is a genotyping technique that exploits the specificity of PCR primers designed to anneal preferentially to one allele of a single nucleotide polymorphism (SNP), thereby amplifying only the target variant while minimizing non-specific amplification of the other allele. This method relies on the incorporation of a deliberate mismatch at the 3' terminus of the primer, which corresponds to the SNP site, preventing efficient extension by the DNA polymerase if the primer binds to the mismatched allele. To enhance discrimination, an additional destabilizing mismatch is often introduced one or two bases upstream from the 3' end, further reducing primer annealing to the non-target allele under optimized PCR conditions. Key variants of AS-PCR include the amplification refractory mutation system (ARMS-PCR), originally developed for detecting point , and primer-induced restriction analysis (PIRA-PCR). In ARMS-PCR, -specific primers are used in separate reactions or, in the tetra-primer format, co-amplified in a single reaction with inner -specific primers and outer common primers to produce distinct amplicon sizes for each . PIRA-PCR modifies the approach by introducing a primer mismatch that creates an artificial recognition site in the amplicon of one but not the other, allowing post-amplification differentiation via , though the core discrimination occurs during the -specific amplification step. Both variants enable reliable SNP genotyping with high specificity for biallelic variants. Detection of AS-PCR products typically involves to visualize the presence or absence of amplicons specific to each , providing a straightforward qualitative assessment of . For , real-time PCR adaptations incorporate fluorescent probes or intercalating dyes to monitor allele-specific amplification in , enabling higher throughput and reduced hands-on time without post-PCR processing. These detection strategies make AS-PCR suitable for both low- and medium-throughput applications. AS-PCR offers several advantages, including simplicity in setup and execution, low cost due to reliance on standard reagents and equipment, and the potential for a limited number of SNPs in a single reaction, such as through tetra-primer formats. It is particularly effective for targeted in resource-limited settings and has been widely adopted for validating SNPs in clinical and contexts. A 2025 comparative study of PCR-based methods for the challenging class IV T-to-A SNP rs9939609 in the demonstrated that both ARMS-PCR and PIRA-PCR achieved over 99% accuracy across diverse sample sets, outperforming some alternatives in specificity for difficult variants with high or secondary structure propensity.

Flap Endonuclease

The flap endonuclease (FEN) method for SNP genotyping, commercialized as the Invader assay, relies on the structure-specific cleavage activity of FEN enzymes to discriminate single nucleotide polymorphisms (SNPs) in target DNA. The assay involves two overlapping oligonucleotides: an invader probe that hybridizes upstream of the SNP site and an allele-specific probe that hybridizes across the SNP, forming a three-dimensional "flap" structure only when the probe perfectly matches the target allele. The FEN enzyme, such as Cleavase derived from Thermus aquaticus DNA polymerase, recognizes this overlapping flap and cleaves the 5' arm of the allele-specific probe at the junction point, releasing a short oligonucleotide flap. This cleavage is highly specific, occurring with minimal mismatch tolerance due to the enzyme's preference for perfectly matched structures, akin to but distinct from the 5' nuclease activity used in other assays. The released flap then hybridizes to a separate fluorescent reporter probe containing a fluorescence resonance energy transfer (FRET) cassette, triggering a secondary cleavage by FEN that separates a fluorophore from a quencher, generating a detectable fluorescent signal proportional to the allele present. This signal amplification is linear and isothermal, avoiding the exponential amplification of PCR and thus eliminating biases from preferential amplification of alleles. Detection can be performed in real-time or endpoint formats using standard fluorescence readers, with sensitivity down to femtomolar levels of target DNA. The method was pioneered through the discovery of FEN's cleavage properties in the early 1990s and adapted for genotyping by Third Wave Technologies, which commercialized the Invader assay in the late 1990s. A key advantage of the is its capability, allowing of up to 100 SNPs in a single reaction through pre-amplification of target regions via multiplex followed by parallel invasive cleavages, each with distinct fluorescent labels. This approach supports high-throughput applications, such as genome-wide association studies, with reported accuracy exceeding 99% and low failure rates under optimized conditions. The assay's reliance on enzymatic cleavage rather than hybridization stability alone enhances specificity for SNPs in complex genomic backgrounds.

Primer Extension

Primer extension, also known as minisequencing or single-nucleotide primer extension (SNuPE), is an enzymatic method for genotyping that involves the extension of a primer annealed immediately upstream of the polymorphic site using and allele-specific dideoxynucleoside triphosphates (ddNTPs). This technique, pioneered in the late 1990s, allows for the incorporation of a single labeled complementary to the , terminating extension and enabling discrimination. Common implementations include , a commercial single-base extension , and broader minisequencing protocols adaptable to various formats. The protocol typically begins with PCR amplification of the target region containing the to generate a , followed by purification to remove unincorporated primers and dNTPs. An unlabeled primer is then annealed to the single-stranded product immediately adjacent to the SNP site, and a , such as Thermo Sequenase, extends the primer by adding one fluorescently labeled ddNTP (e.g., ddATP, ddCTP, ddGTP, or ddTTP) specific to the present, with different colors assigned to each for . The reaction is cycled (e.g., 26 cycles at optimized Mg²⁺ concentrations) to enhance yield, and unincorporated ddNTPs are removed via enzymatic digestion or cleanup. Detection is achieved through on instruments like the 3730xl Genetic Analyzer, where extension products are separated by size and , allowing simultaneous analysis of up to 10 SNPs per reaction with software like GeneMapper for calling. This method offers high accuracy for heterozygous genotype calls, with error rates as low as 0.003, as validated against array-based platforms, due to the direct incorporation of allele-specific signals. It also effectively handles SNPs near insertions/deletions (indels), genotyping up to 87% of such variants successfully, as the upstream primer annealing site can be designed to avoid affected regions. Automated since the early through commercial kits and instrumentation, primer extension supports high-throughput processing, yielding up to 42,000 genotypes per day. Applications include panels for individual SNPs and clinical diagnostics, such as multiplex assays for mutations in genes like PAH in , achieving 100% detection rates in targeted populations.

5'-Nuclease Assay

The 5'-nuclease assay, also known as the assay, is a widely adopted PCR-based method for (SNP) genotyping that leverages the intrinsic 5'-3' activity of (Taq) to generate allele-specific fluorescent signals during amplification. Introduced in the early 1990s, this homogeneous, closed-tube technique enables high-throughput genotyping without post-PCR processing, making it suitable for discriminating biallelic SNPs in diverse applications such as and . The assay's reliability stems from its ability to detect subtle differences in probe-target hybridization stability, achieving genotyping accuracy exceeding 99% in validated systems. Probe design is critical for specificity, featuring two competing oligonucleotide probes, each complementary to one allele of the SNP. Each probe is approximately 13-30 nucleotides long, with a fluorescent reporter dye attached to the 5' end—typically 6-carboxyfluorescein (FAM) for one allele and VIC for the other—and a non-fluorescent quencher moiety, such as minor groove binder (MGB) or 6-carboxytetramethylrhodamine (TAMRA), at the 3' end to suppress fluorescence in the intact state. The polymorphic nucleotide is positioned in the central third of the probe sequence to optimize mismatch discrimination, as a single base mismatch with the non-complementary allele reduces hybridization stability and prevents efficient cleavage. Probes are paired with locus-specific PCR primers, and the overall design ensures a melting temperature (Tm) of 65-67°C for the probes to align with the 60°C annealing temperature commonly used in the assay. In the mechanism, during each PCR cycle, the probes anneal to their target sequences if perfectly matched. As Taq polymerase extends the upstream primer, its 5' nuclease domain hydrolyzes the 5' end of the annealed probe, separating the reporter dye from the quencher and producing a proportional increase in fluorescence that accumulates over cycles. Mismatched probes fail to anneal stably and are not cleaved, resulting in no signal for that allele. This process occurs in real-time, but genotyping is typically performed via endpoint analysis after 40-50 cycles. Genotype determination relies on the ratio of endpoint fluorescence from the two reporter dyes, plotted on a two-dimensional scatter where samples cluster into three distinct groups: homozygotes for the VIC-labeled (high VIC, low FAM), homozygotes for the FAM-labeled (low VIC, high FAM), and heterozygotes (intermediate levels of both). amplification curves can also aid in clustering by monitoring signal accumulation kinetics, though endpoint reading suffices for most applications. Automated software on instruments like the 7500 Fast PCR System facilitates cluster calling and quality control. Commercially, the SNP Genotyping Assays developed by (now ) have been a cornerstone of the field since the late , with predesigned assays available for over 17 million , including those from the HapMap and 1000 Genomes projects. These assays support medium- to high-throughput of hundreds to thousands of samples per SNP, with typical reaction volumes of 5-25 μL and costs enabling analysis of more than 1,000 SNPs in large cohorts. The platform's integration with multi-color detection has expanded its use to duplex or multiplex formats for simultaneous SNP analysis.

Oligonucleotide Ligation Assay

The (OLA) is a genotyping method that exploits the high fidelity of enzymes to discriminate () by joining adjacent hybridized to target only when there is a perfect base match at the junction. In this assay, two probes are designed to anneal to the target : an allele-specific probe with its 3' terminus positioned at the polymorphic site and a locus-specific probe adjacent to it on the 5' side. Thermostable ligases, such as () , catalyze the formation of a between the probes if the allele-specific probe perfectly matches the SNP allele; a single-base mismatch at the 3' end of the allele-specific probe substantially inhibits due to the enzyme's to distortions in the . This principle was first demonstrated for detection in 1988 and later adapted for . Variants of OLA enhance its utility for high-throughput applications, including integration with amplification of the ligated products to generate detectable signals from low-abundance targets. Another variant, ligation-rolling circle (L-RCA), employs circularizable "padlock" probes that, upon allele-specific , form closed circles amenable to exponential isothermal amplification by phi29 , enabling sensitive detection without initial . These approaches maintain the core ligation specificity while amplifying signals for analysis in diverse sample types, such as genomic DNA directly from or . Detection of ligated products in typically involves labeling strategies followed by separation and readout. Common methods include incorporating fluorescent tags on the probes, amplifying ligated products via with universal primers, and resolving alleles by or based on size differences. Alternatively, biotinylated probes can be captured on streptavidin-coated surfaces or microarrays for fluorescence-based detection, allowing of dozens of SNPs. The SNPlex platform exemplifies this by performing multiplex on up to 48 SNPs per sample, using zip-coded probes that ligate allele-specifically, followed by universal and for automated allele calling with >99% accuracy in large-scale studies. OLA offers advantages in specificity and simplicity for SNP genotyping, as the ligase's mismatch discrimination exceeds that of many hybridization-based methods, reducing false positives in complex samples. It has been particularly valuable in forensic applications, where its tolerance for degraded DNA and ability to multiplex ancestry-informative SNPs aid in human identification and relationship testing from limited or compromised evidence. Unlike primer extension techniques, OLA achieves discrimination through probe joining without enzymatic nucleotide addition.

Physical Property-Based Methods

Single-Strand Conformation Polymorphism

Single-strand conformation polymorphism (SSCP) is a method for detecting single nucleotide polymorphisms (SNPs) by exploiting differences in the electrophoretic mobility of single-stranded DNA fragments under non-denaturing conditions. The principle relies on the fact that denatured DNA strands fold into unique three-dimensional conformations determined by intrastrand base pairing, and a single base substitution caused by an SNP can alter this folding pattern, leading to distinct migration rates during polyacrylamide gel electrophoresis (PAGE). This technique was first described for identifying DNA polymorphisms in human genes, where sequence variations as small as one nucleotide change the conformational stability enough to produce detectable band shifts. The standard protocol for SSCP in SNP genotyping begins with genomic DNA isolation, typically from blood samples using proteinase K digestion followed by phenol-chloroform extraction. The target region containing the potential SNP is then amplified via polymerase chain reaction (PCR) to produce fragments ideally 150-250 base pairs in length. Post-amplification, the double-stranded PCR products are denatured by heating in the presence of formamide to separate the strands, after which they are rapidly cooled to allow renaturation into single-stranded conformations. The denatured samples are loaded onto a non-denaturing polyacrylamide gel (usually 5-12% ) and subjected to electrophoresis at low temperature (e.g., 4-20°C) to preserve the secondary structures. Visualization is achieved through silver for unlabeled DNA or autoradiography for radioactively labeled samples, revealing mobility shifts indicative of SNPs. SSCP demonstrates high sensitivity for SNP detection, identifying over 90% of single base substitutions in fragments shorter than 200 and approximately 80% in those ranging from 300-400 , with optimal performance around 150 base pairs where conformational changes are most pronounced. This makes it particularly effective for screening short amplicons in applications like detection in candidate genes, though detection rates can vary based on the SNP's position within the fragment and the specific sequence context. Despite its utility, SSCP has notable limitations, including labor-intensive manual gel preparation and analysis, which restrict throughput and make it sequence-dependent—certain SNPs may not induce sufficient conformational changes for detection. Additionally, partial reannealing of complementary strands during can reduce sensitivity, necessitating dilute samples and careful optimization of denaturation conditions. The method gained popularity in the for its simplicity and low cost but has been largely supplanted by higher-throughput technologies due to these constraints. Improvements to SSCP have focused on automation and enhanced detection, such as incorporating fluorescent labeling of primers followed by (CE-SSCP), which allows for faster, safer analysis on automated sequencers and improves resolution for multiplexed SNP genotyping. These adaptations maintain the core conformational principle while enabling higher sample processing rates, as demonstrated in panels of functional candidate SNPs.

Denaturing Gradient Methods

Denaturing gradient methods encompass gel-based techniques that exploit the differential melting behaviors of DNA duplexes to detect single nucleotide polymorphisms (SNPs). These methods separate PCR-amplified DNA fragments on polyacrylamide gels subjected to controlled gradients of denaturants or temperature, allowing resolution of sequence variants based on their stability under partially denaturing conditions. Developed in the 1980s, they were particularly valuable for mutation scanning in targeted genomic regions prior to the widespread adoption of high-throughput sequencing technologies. The primary variants are denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE). DGGE employs a chemical denaturant gradient, typically composed of 20-80% urea and formamide, which progressively destabilizes DNA double helices as the gel is electrophoresed. In contrast, TGGE uses a temperature gradient, often ranging from 40-70°C, applied across the gel to achieve similar denaturation effects without chemical additives. Both techniques rely on the principle that homo- and heteroduplexes—formed when PCR products containing SNPs reanneal—exhibit distinct melting profiles; a single base mismatch in heteroduplexes lowers the melting temperature, causing the molecule to migrate more slowly or stop earlier in the gradient compared to perfectly matched homoduplexes. A key innovation enhancing sensitivity in these methods is the attachment of a GC-rich (typically 30-50 bp) to one PCR primer, which anchors the duplex at one end and prevents complete strand separation, ensuring partial denaturation reveals sequence-dependent mobility shifts. The protocol begins with PCR amplification of the SNP-containing region (usually 100-500 bp), followed by denaturation and reannealing to promote heteroduplex formation—often by mixing the sample with wild-type DNA or through controlled cooling cycles. The products are then loaded onto a vertical gel (6-8% acrylamide) with the established gradient, electrophoresed at constant voltage (e.g., 100-200 V) for several hours, and visualized by staining with or silver staining, where variant bands appear as distinct patterns offset from the wild-type. These methods excel in applications such as mutation scanning for unknown SNPs in genes of interest, offering near-100% detection rates for variants within the analyzed fragment when optimized, and requiring minimal equipment beyond standard setups. Heteroduplex formation particularly enhances resolution for heterozygous SNPs, making them suitable for population screening in research settings during the pre-sequencing era. However, their labor-intensive nature, need for gradient optimization per sequence, and low throughput have led to decreased use following the rise of next-generation sequencing, which provides more scalable and precise .

Denaturing High-Performance Liquid Chromatography

Denaturing high-performance liquid chromatography (DHPLC) is a technique that detects single nucleotide polymorphisms (SNPs) by separating DNA homoduplexes from heteroduplexes formed during partial denaturation of PCR-amplified fragments. It relies on ion-pair reversed-phase high-performance liquid chromatography, where DNA molecules are separated on a nonporous polystyrene-divinylbenzene column under partially denaturing conditions at elevated temperatures, typically 60–70°C. Heteroduplexes, which contain mismatched base pairs due to SNPs, exhibit reduced thermal stability and weaker hydrophobic interactions with the column, causing them to elute earlier than stable homoduplexes. This differential elution is monitored by UV absorbance at 260 nm, producing distinct chromatograms that indicate the presence of variants. The protocol begins with PCR amplification of the target DNA region using high-fidelity polymerase to generate sufficient product, followed by denaturation at 95°C for 5 minutes and controlled reannealing via slow cooling (e.g., 1°C per minute to ambient temperature over 30–45 minutes) to promote heteroduplex formation in heterozygous samples. The resulting mixture is then injected onto the column, where separation occurs using a linear acetonitrile gradient (e.g., 15–35% in 0.1 M triethylammonium acetate buffer, pH 7.0) at an optimized temperature predicted by software based on fragment size and GC content. Analysis time per sample is approximately 5–10 minutes, with automated injection enabling high-throughput processing. Unlike denaturing gradient gel electrophoresis, DHPLC uses liquid chromatography for non-gel-based separation, allowing faster turnaround without electrophoresis. DHPLC achieves high resolution for detection, with sensitivity exceeding 95% for base substitutions and small insertions/deletions in amplicons up to 1.5 (optimally 100–500 bp), and it can identify or minor variants at levels as low as 2–2.5% in pooled samples. Specificity ranges from 87–100%, depending on fragment design and conditions, making it reliable for scanning large genes or populations. The commercial system, introduced by Transgenomic in the late , automates this process using a DNASep cartridge and Navigator software for temperature and gradient optimization, supporting unattended analysis of up to 96 samples per run and throughput of approximately 100–200 samples per day. Compared to traditional gel-based methods like single-strand conformation polymorphism, DHPLC offers advantages including no need for radioactive labeling, quantitative peak area measurements for estimation, reduced hands-on time due to , and lower cost per sample (approximately $0.50–1.00 versus $2–5 for sequencing confirmation). It has been widely adopted for mutation scanning in genes associated with diseases like , enabling rapid identification of SNPs in clinical and research settings.

High-Resolution Melting Analysis

High-resolution melting (HRM) analysis is a post-PCR technique used for SNP genotyping that relies on the precise monitoring of DNA duplex dissociation through fluorescence changes as temperature increases. Intercalating dyes, such as EvaGreen or SYBR Green, bind to double-stranded DNA amplicons during PCR amplification, and their fluorescence decreases as the DNA melts into single strands, producing characteristic melting curves that differ based on sequence variations like SNPs. SNPs alter the melting temperature (Tm) of amplicons, with G/C base pairs typically raising Tm by 1-2°C compared to A/T pairs due to stronger hydrogen bonding and stacking interactions, enabling genotype distinction without enzymatic or probe-based steps. This method was first demonstrated for SNP genotyping in a seminal 2004 study, which highlighted its simplicity using only PCR, a DNA dye, and melting instrumentation on real-time PCR systems. The protocol integrates HRM directly with real-time on instruments equipped for high-resolution , such as those with sensitive detectors. Following standard amplification of a target region containing the (typically 80-150 in length), a step ramps the temperature from 60°C to 95°C in 0.1°C increments while continuously recording . are plotted as versus temperature to generate melting curves, which are normalized and analyzed using the negative first (-dF/dT) to identify Tm peaks, allowing visualization of sequence-specific patterns. Saturating dyes like EvaGreen are preferred over SYBR Green for their higher binding capacity and lack of inhibition, providing sharper resolution for subtle Tm shifts. Genotype discrimination in HRM exploits the formation of homoduplexes and heteroduplexes during the PCR cooling phase. Homozygous samples produce two distinct Tm peaks or curves corresponding to the uniform sequences, while heterozygous samples form heteroduplexes with mismatched bases that melt at lower temperatures, resulting in a broader or shifted curve. This approach reliably distinguishes common biallelic SNPs, with accuracy exceeding 99% in validated assays for targets like those in the TP53 gene, as shown in comparative studies against sequencing. Advances in HRM include the concomitant amplification and detection method with HRM (CADMA-HRM), which uses a three-primer system to simultaneously amplify wild-type and mutant alleles, enhancing sensitivity for challenging SNPs with minimal Tm differences, such as T-to-A transversions. Recent modifications to CADMA-HRM, reported in studies, have extended its application to indels and low-frequency variants by improving assay robustness on standard qPCR platforms, maintaining the method's cost-effectiveness (under $0.50 per sample) and probe-free nature. These developments position HRM as a scalable tool for high-throughput in clinical and research settings. Despite its advantages, HRM has limitations, including a recommended amplicon length under 300 to ensure sufficient resolution of Tm differences, as longer fragments dilute SNP-specific signals. Sequence context, such as high or adjacent polymorphisms, can confound interpretation by altering baseline Tm or introducing multiple peaks, necessitating careful primer design and validation against known standards.

Mismatch-Binding and Nuclease Assays

Mismatch-binding and nuclease assays exploit the structural distortions in DNA heteroduplexes formed by annealing strands with single nucleotide polymorphisms (SNPs), allowing proteins or enzymes to recognize and process these mismatches for detection. These methods are particularly useful for mutation scanning in PCR-amplified regions, where heteroduplexes are generated by denaturation and reannealing of DNA from heterozygous samples. Unlike direct sequencing, they provide rapid, cost-effective screening without requiring allele-specific probes. Mismatch-binding proteins, such as homologs of the bacterial MutS protein, specifically recognize and bind to bulges, bubbles, or loops caused by SNPs in heteroduplex DNA, typically detected through electrophoretic mobility shifts. In the DNA retardation assay, PCR products (200–700 bp) are incubated with 1–3 μg of thermostable MutS from Thermus thermophilus, followed by polyacrylamide gel electrophoresis and staining with SYBR-Gold to visualize the slower-migrating protein-DNA complexes. This approach detects single-base substitutions and small insertions/deletions with high specificity, making it suitable for genotyping clinical samples containing point mutations. Chimeric MutS fusions with reporter enzymes like β-galactosidase or fluorescent proteins such as GFP enable solid-phase immobilization and signal amplification, allowing detection of minute DNA quantities directly from genomic samples without prior PCR. These MutS-based methods offer sensitivity for low-abundance variants but are primarily used for qualitative scanning rather than quantitative allele calling. Nuclease assays employ structure-specific enzymes that cleave DNA at or near mismatch sites in heteroduplexes, producing fragments resolvable by gel electrophoresis. The Surveyor nuclease, derived from CEL I (a celery endonuclease), is a single-strand-specific enzyme that cleaves both strands at the 3' side of mismatches, including SNPs and small indels up to 12 nucleotides. The protocol involves PCR amplification of the target region, denaturation at 95°C followed by gradual reannealing to form heteroduplexes, incubation with Surveyor nuclease at 42°C for 20–60 minutes in Mg²⁺-containing buffer, and analysis of cleavage products (typically 100–500 bp) via polyacrylamide gel electrophoresis. This method detects heterozygous variants at frequencies as low as 1 in 32 copies (approximately 3%), enabling high-throughput SNP discovery in large genomic fragments exceeding 2.9 kb. Similarly, T7 endonuclease I, a resolvase from bacteriophage T7, cleaves heteroduplexes at mismatch-induced bubbles or loops, with a protocol mirroring Surveyor's but using incubation at 37°C for 15–30 minutes. Commercialized for applications like CRISPR validation, T7 endonuclease I shows comparable sensitivity (1–10% variant detection) and is preferred for deletions over Surveyor due to higher efficiency on certain substrates, though it may require multiple reactions to minimize false negatives (up to 70% in some SNP contexts). Both nucleases are applied in scanning modes for mutation mapping, not precise genotyping, and are cost-effective alternatives to sequencing for initial variant identification in research and diagnostics.

Mass Spectrometry-Based Methods

MALDI-TOF Mass Spectrometry

Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry enables SNP genotyping by ionizing post-PCR or products and measuring their mass-to-charge ratios to differentiate alleles based on subtle mass differences. For instance, incorporation of versus in extension products results in a 16 Da mass shift due to their respective weights of 313 Da and 329 Da, allowing resolution of homozygous and heterozygous genotypes through distinct spectral peaks. This direct mass analysis avoids indirect detection methods, providing unambiguous allele identification even for challenging SNPs. The protocol begins with PCR amplification of the genomic region containing the SNP, followed by a single-base primer extension reaction adjacent to the polymorphic site using a polymerase, dNTPs, and termination mix to generate allele-specific products. Excess nucleotides are removed by incubation with shrimp alkaline phosphatase (SAP) at 37°C for 30-60 minutes to dephosphorylate unincorporated dNTPs, minimizing spectral noise; the enzyme is then inactivated by heat. Purified extension products are desalted, mixed with a UV-absorbing MALDI matrix such as alpha-cyano-4-hydroxycinnamic acid, and spotted onto a stainless steel target plate. A nitrogen laser desorbs and ionizes the sample, propelling singly charged ions through a field-free drift tube in the TOF analyzer, where flight time correlates inversely with the square root of mass, yielding spectra for genotype calling. The Sequenom MassARRAY iPLEX platform exemplifies a key , supporting automated, high-throughput with multiplexing capacities of up to 40 SNPs per reaction well through optimized primer design that spaces mass signals to prevent overlap. Developed in the early 2000s amid the Project's push for scalable , this method has evolved to handle thousands of samples daily with minimal hands-on time. MALDI-TOF offers advantages including fluorescence-free detection for unbiased mass readout, robust performance across diverse sample types, and genotyping accuracy greater than 99% with call rates often exceeding 98% in multiplex formats. These attributes stem from the technique's high mass resolution (down to 1-3 Da) and sensitivity to low DNA inputs (1-10 ng). In applications, it has powered large-scale research, such as associating CYP450 SNPs with drug efficacy and adverse reactions in cohorts of thousands, facilitating advancements since its widespread adoption around 2000. The platform, now under Agena Bioscience, continues to be used for SNP genotyping as of 2025.

Electrospray Ionization Mass Spectrometry

Electrospray ionization mass spectrometry (ESI-MS) enables SNP genotyping by generating multiply charged ions from DNA samples in solution, allowing the analysis of mass-to-charge ratios (m/z) to identify allelic variations based on subtle mass differences, such as 9 Da for A↔T or 40 Da for G↔C substitutions. This soft ionization technique preserves intact biomolecules, producing a series of adjacent peaks corresponding to different charge states, which facilitates accurate mass determination through deconvolution algorithms that reconstruct the neutral molecular mass. For more complex analyses, tandem MS (MS/MS) is employed, where precursor ions are fragmented in a collision cell to yield daughter ions, revealing sequence-specific fragmentation patterns that confirm SNP compositions without enzymatic digestion. The typical protocol begins with PCR amplification of target regions containing the SNPs, followed by cleanup to remove salts, primers, and unincorporated nucleotides that could cause ion adduction and spectral broadening. Cleanup is achieved via , digestion, or online chromatographic desalting, after which the purified amplicons are introduced into the ESI source via a capillary needle under (typically 2-5 kV), nebulized with a gas, and ionized. The resulting ions enter the mass analyzer—often a or time-of-flight (TOF) instrument—where spectra are acquired and deconvoluted to assign allele-specific masses; for MS/MS, selected precursors are isolated and fragmented to generate confirmatory spectra. This process supports direct genotyping of heterozygous and homozygous SNPs from amplicons up to several hundred base pairs. Key advantages of ESI-MS include its ability to handle longer DNA fragments (>100 bp) compared to other mass spectrometry methods, owing to the multiple charging that reduces m/z values into a detectable range, and its capacity to distinguish sequence isomers through MS/MS fragmentation, which provides structural detail beyond mere mass shifts. Additionally, the technique offers high mass accuracy (often <20 ppm) and sensitivity down to picogram levels of input DNA, enabling robust genotyping without fluorescent labeling or immobilization steps. Commercial platforms such as the Ibis PLEX-ID system, which integrated ESI-TOF MS, were widely adopted for forensic applications, including multiplexed panels of 40 autosomal SNPs for human identification and mixture deconvolution, until its discontinuation by Abbott in 2017. These systems automated PCR setup, desalting, and data analysis, achieving near-100% sensitivity from 100 pg DNA per reaction and supporting SNP/indel detection in degraded samples. Post-2010 developments enhanced automation and throughput for ESI-MS, but following the PLEX-ID discontinuation, the method has seen reduced use in routine SNP genotyping, with applications shifting toward research in proteomics and other biomolecular analyses as of 2025.

Sequencing-Based Methods

Sanger Sequencing

Sanger sequencing, also known as chain-termination sequencing, relies on the incorporation of dideoxynucleotide triphosphates (ddNTPs), which lack a 3'-hydroxyl group and thus terminate DNA polymerase-mediated strand extension upon incorporation. In the automated fluorescent variant, four distinct fluorescent dyes are conjugated to the ddNTPs (one for each base: ddATP, ddTTP, ddGTP, and ddCTP), enabling the simultaneous generation and detection of termination fragments in a single reaction tube. This four-color detection system revolutionized the method by replacing labor-intensive radioactive labeling and gel lane separation with capillary-based fluorescence reading. The protocol for SNP genotyping using Sanger sequencing begins with PCR amplification of the target genomic region containing the SNP of interest, typically using high-fidelity polymerases to generate clean templates of 200-500 base pairs. This is followed by cycle sequencing, where the purified PCR product serves as a template for linear amplification with a sequencing primer, DNA polymerase, normal dNTPs, and fluorescently labeled ddNTPs under thermal cycling conditions to produce a ladder of terminated fragments. The fragments are then separated by size via capillary electrophoresis on automated systems such as Applied Biosystems (ABI) 3730 or 3500 Genetic Analyzers, where a laser excites the dyes, and a detector records emission spectra to generate a chromatogram. SNP calling involves inspecting the resulting electropherogram for peak patterns at the position of interest: a single dominant peak indicates homozygosity, while overlapping double peaks of roughly equal height signify heterozygosity. Manual visual inspection is essential to distinguish true heterozygous signals from artifacts like dye blobs or compression, though software tools such as or can automate base calling with user verification. Due to its read lengths of up to 800-1000 bases and error rate below 0.01%, Sanger sequencing remains the gold standard for validating SNPs identified by higher-throughput methods. With a throughput limited to approximately 1-10 SNPs per sample per run, Sanger sequencing is ideal for targeted validation rather than genome-wide analysis. However, its high per-sample cost—around $5-10 per SNP—and labor-intensive workflow have made it unsuitable for large-scale genotyping, leading to its phase-out for routine applications after 2010 in favor of more scalable technologies.

Next-Generation Sequencing

Next-generation sequencing (NGS) has transformed SNP genotyping by enabling massively parallel sequencing of DNA fragments, allowing the simultaneous interrogation of millions of potential SNP sites across whole genomes or targeted amplicon panels with high sensitivity and specificity. Unlike traditional Sanger sequencing, which processes one DNA fragment at a time, NGS platforms generate billions of short reads in a single run, facilitating de novo SNP discovery and precise genotyping in diverse applications such as population genetics and clinical diagnostics. This approach achieves per-base accuracies exceeding 99.9% when validated against Sanger sequencing, making it a gold standard for variant detection. Key NGS platforms for SNP genotyping include Illumina's sequencing-by-synthesis (SBS) systems, which utilize reversible terminator nucleotides and fluorescent imaging to detect base incorporation during DNA synthesis on a flow cell. Ion Torrent platforms employ semiconductor technology to measure pH changes resulting from proton release during nucleotide incorporation, offering rapid turnaround times for targeted SNP panels. Pacific Biosciences (PacBio) systems use single-molecule real-time (SMRT) sequencing, where a polymerase incorporates fluorescently labeled nucleotides in zero-mode waveguides, producing long reads (up to 20 kb) that improve SNP calling in repetitive or structurally complex genomic regions. These platforms differ in read length, throughput, and error profiles, with Illumina providing the highest accuracy for short-read SNP genotyping, Ion Torrent excelling in speed for smaller panels, and PacBio aiding in resolving ambiguous variants through longer context. The typical NGS workflow for SNP genotyping begins with library preparation, involving genomic DNA fragmentation (e.g., via sonication or enzymatic methods), end repair, A-tailing, and adapter ligation to enable sequencing compatibility. Amplification follows, using emulsion PCR on beads for Ion Torrent to clonally expand fragments or bridge amplification on a flow cell surface for Illumina to form clusters. Sequencing then occurs in a massively parallel manner: for Illumina, iterative cycles of nucleotide addition and imaging; for Ion Torrent, sequential flow of unlabeled nucleotides with real-time pH detection; and for PacBio, continuous real-time monitoring of polymerase activity. Post-sequencing, raw reads undergo quality trimming and demultiplexing before analysis. SNP calling in NGS data involves aligning short reads to a reference genome using tools like Burrows-Wheeler Aligner (BWA), which efficiently maps reads while accounting for mismatches indicative of SNPs. Variant calling then employs probabilistic models in software such as the Genome Analysis Toolkit (), which applies machine learning to distinguish true SNPs from sequencing artifacts based on read depth, mapping quality, and allele balance. Reliable SNP genotyping typically requires a minimum read depth of 30x at target loci to achieve >99% accuracy, as lower coverage increases false positives and negatives. Hard filtering or variant quality score recalibration in GATK further refines calls by excluding low-confidence variants. NGS offers significant advantages for SNP genotyping, including the ability to profile millions of SNPs per sample with per-base error rates below 0.1%, enabling comprehensive genome-wide association studies and rare variant detection. By 2025, targeted NGS panels have reduced costs to approximately $0.01 per SNP, driven by in high-throughput platforms and declining reagent prices, making it more accessible than earlier methods. However, platform-specific biases must be mitigated: variations can cause uneven coverage, with high-GC regions often underrepresented in Illumina data due to inefficient amplification. Homopolymer stretches are particularly error-prone in Ion Torrent sequencing, where signal decay leads to insertion/deletion inaccuracies, while PacBio exhibits lower bias in these areas but higher overall raw error rates (~13%). Computational corrections, such as normalization in , help address these issues to ensure robust .

Genotyping-by-Sequencing

Genotyping-by-sequencing (GBS) is a high-throughput for discovering and genotyping single nucleotide polymorphisms (SNPs) by reducing genome complexity through digestion, followed by next-generation sequencing (NGS) of the resulting fragments. Developed in , GBS enables cost-effective analysis of large populations without requiring a , making it particularly suitable for species with high or limited genomic resources. The approach was first described using the ApeKI, which targets GCWGC sites and produces 5' overhangs compatible with adapter ligation, allowing for the selective amplification and sequencing of low-copy genomic regions. The protocol for GBS begins with the digestion of genomic DNA (typically 100-200 ng per sample) using ApeKI or similar enzymes, followed by the ligation of a unique barcode adapter to the overhangs and a common sequencing adapter to facilitate multiplexing. The ligated fragments are then pooled, purified to remove small products, and subjected to PCR amplification (typically 18-20 cycles) to generate the sequencing library, with size selection often focusing on 200-500 bp fragments to enrich for informative regions. Libraries are sequenced using platforms like Illumina, yielding short single-end reads (e.g., 64-100 bp) at depths sufficient for SNP detection (around 0.1-1x coverage per locus across the reduced representation). This streamlined process, completable in a few days, supports genotyping of thousands of samples at costs under $50 per sample when scaled. GBS is widely applied in studies to assess diversity and structure, as well as in (QTL) mapping for traits like biomass yield in and disease resistance in animals, often identifying over 10,000 SNPs per without prior sequence knowledge. For variant calling, reads are demultiplexed by barcodes, quality-filtered, and either assembled de novo into tags for novel SNP discovery or mapped to a using tools like BWA, with genotypes inferred via likelihood models that accommodate and . Variants of GBS, such as restriction-site associated DNA sequencing (RAD-seq) developed in 2008 using enzymes like , and double-digest RAD-seq (ddRAD-seq) introduced in 2012 with paired enzymes (e.g., and NlaIII) for tunable fragment sizes, offer customization for specific marker densities and multiplexing needs. These methods have enabled de novo in non-model organisms, supporting applications from evolutionary studies to programs.

Emerging Methods

CRISPR-Cas Systems

CRISPR-Cas systems have emerged as powerful tools for SNP genotyping by leveraging the programmable nucleic acid recognition and collateral cleavage activity of Cas enzymes to detect single-base variations with high specificity and sensitivity. Originally developed for genome editing, these systems have evolved for diagnostic applications, enabling isothermal detection without the need for thermal cycling or complex equipment. In SNP genotyping, a guide RNA (gRNA) is designed to hybridize with the target DNA or RNA sequence adjacent to a protospacer adjacent motif (PAM) for Cas12 or a protospacer flanking sequence (PFS) for Cas13; upon perfect match binding, the Cas enzyme activates and indiscriminately cleaves reporter molecules, producing a detectable signal only for the matched allele. The mechanism relies on the enzyme's collateral activity: Cas13a, for instance, cleaves non-target RNA reporters after binding to target RNA, while Cas12a cleaves single-stranded DNA reporters following target DNA recognition. Specificity for single-base discrimination arises from mismatches in the gRNA-target duplex, particularly in the seed region (positions 1-8 from the PAM) or through engineered synthetic mismatches in the gRNA, which prevent activation for variant alleles; this allows differentiation of SNPs with minimal cross-reactivity. Key variants include , which uses Cas13a combined with (RPA) for isothermal pre-amplification of target nucleic acids, followed by T7 transcription to generate targets for Cas13a detection. achieves attomolar sensitivity and has been applied to human at multiple loci, such as those associated with , with accurate discrimination of heterozygous and homozygous variants. Similarly, DETECTR employs Cas12a with RPA for direct DNA detection, enabling rapid genotyping of polymorphisms like those in human papillomavirus strains, where single-base mismatches in the seed region reduce signal by over 90%. Detection outputs include from cleaved reporters for quantitative readouts in lab settings or colorimetric assays via gold nanoparticle aggregation or lateral flow strips for visual interpretation, often integrated in one-pot reactions completing in under 60 minutes. These methods support point-of-care applications, with lyophilized reagents enabling field-deployable, low-cost (~$0.61 per test) in resource-limited environments. Recent advances from 2023 to 2025 highlight the transition from editing-focused to detection-oriented Cas12 and Cas13 systems, with enhancements in for simultaneous analysis and improved PAM/seed-based strategies for enhanced single-base fidelity, as seen in diagnostics for viral variants and cancer mutations. These developments underscore CRISPR-Cas's role in portable, isothermal genotyping, surpassing traditional PCR-based methods in speed and simplicity while maintaining high accuracy.

Lateral Flow and Biosensor Assays

Lateral flow assays (LFAs) for SNP genotyping combine amplification techniques, such as , with immunochromatographic detection on formats to provide rapid, visual genotype identification. These assays typically employ allele-specific primers labeled with and a (e.g., or digoxigenin) to selectively amplify target SNPs during the initial amplification step. The resulting amplicons are then applied to a nitrocellulose-based , where gold nanoparticles conjugated to anti-hapten antibodies enable colorimetric visualization through . The protocol begins with and amplification using (LNA)-modified primers for enhanced specificity, followed by hybridization of the biotin- and hapten-labeled products with immobilized probes on the dipstick. As the sample migrates along the strip, unbound components pass the test line, while specific matches accumulate gold nanoparticle complexes at the test line, forming a visible red band; a control line, coated with or anti-biotin antibodies, always develops to validate the . This migration and detection step typically requires 15–20 minutes post-amplification, yielding results interpretable by eye without instrumentation. In 2025, a PCR-LFD method was established for the visual detection of the MC4R g.732 C > G SNP in Hu sheep, associating genotypes (CC, CG, GG) with growth traits and completing the entire process in 1.5 hours. This approach demonstrated 100% concordance with Sanger sequencing for 24 samples, highlighting its reliability for on-site applications. Biosensor assays extend LFA principles by incorporating electrochemical or optical transduction for quantitative SNP readout, often integrated with nanomaterials like graphene for improved sensitivity. Optical biosensors leverage graphene's fluorescence quenching properties, where single-stranded DNA adsorbs strongly to the surface, quenching fluorophores, while perfect-match ligation forms double-stranded DNA that desorbs and restores signal for SNP discrimination. Such graphene-based optical systems detect SNP frequencies as low as 2.6% within 40 minutes. These lateral flow and assays offer key advantages for SNP genotyping, including field-deployability due to their portability and lack of need for power or complex readers, low cost (typically under $1 per test), and potential for through color-coded nanoparticles or multi-channel signals. They achieve high (e.g., 97.96% for parasite-associated SNPs) and specificity (up to 100%), making them suitable for resource-limited settings like antimalarial resistance monitoring.

Proteomic Genotyping

Proteomic genotyping infers genotypes of single nucleotide polymorphisms (SNPs) by analyzing protein variants produced from non-synonymous SNPs, which result in single amino acid polymorphisms (SAPs) within peptides. These SAPs cause measurable mass shifts in peptides detectable by mass spectrometry (MS), allowing indirect determination of DNA sequences without nucleic acid extraction. This approach leverages the genetic code's translation from DNA to proteins, focusing on coding regions where nucleotide changes alter amino acid composition. The protocol begins with protein extraction from biological samples, followed by enzymatic digestion—typically using —to produce peptides containing potential SAPs. These peptides are then separated and analyzed via liquid chromatography-tandem (LC-MS/MS), where high-resolution MS identifies mass-to-charge ratios and fragmentation patterns. Observed spectra are matched against databases of predicted genetically variant peptides (GVPs) derived from known catalogs, such as those from the , to infer the corresponding SNP genotypes. Advances in high-resolution (HRMS) post-2020 have improved resolution for distinguishing subtle mass differences (e.g., 1 Da shifts from substitutions). In forensic applications, proteomic genotyping enables human identification from challenging samples like hair shafts, fingermarks, and bones where DNA is degraded or insufficient. For instance, 2025 reviews emphasize its utility in missing persons investigations and disaster victim identification by linking proteomic data to DNA databases for probabilistic matching. It provides a complementary bridge between genomic and proteomic profiles, enhancing intelligence from trace evidence. Key advantages include the chemical stability of proteins, which persist better than DNA in environmentally degraded samples such as buried bones or heat-exposed remains, allowing in scenarios where traditional DNA methods fail. Validation studies demonstrate high concordance rates exceeding 90% between MS-inferred genotypes and direct for targeted SNPs. However, limitations restrict its scope to non-synonymous coding SNPs that produce detectable SAPs, excluding synonymous or non-coding variants; it also requires comprehensive GVP databases and faces challenges in low-abundance samples.

Data Analysis and Quality Control

Genotype Calling

Genotype calling in SNP genotyping involves algorithmic assignment of discrete genotypes, such as homozygous reference (), heterozygous (), or homozygous alternate (), from raw signal intensities or read alignments generated by various platforms. This process relies on statistical models to interpret noisy data, distinguishing true variants from artifacts while maximizing call accuracy and completeness. Core principles include unsupervised clustering of multidimensional data points, where intensity signals from allele-specific probes are grouped into expected genotype clusters, and probabilistic modeling to estimate genotype likelihoods under uncertainty. Clustering approaches, such as k-means, partition intensity data into 2-3 clusters for diploid SNPs, leveraging platform-specific priors like skewed homozygote distributions in Illumina arrays to improve separation. For instance, adaptive k-means variants adjust cluster numbers based on signal quality predictors, enhancing calls for low-frequency alleles. Bayesian models offer a complementary framework by treating genotype assignment as posterior inference over mixture distributions, such as Gaussian mixtures for data, which incorporate priors on cluster variances and shapes to handle non-normal distributions. A symmetric multinomial logistic regression (SMLR) model, applied to small DNA panels as of 2025, estimates conditional genotype probabilities from allele signals without relying on priors, reducing no-call rates by up to 50% at low input quantities like 31 pg. Dedicated software implements these principles across genotyping methods. For microarray data, Illumina's GenomeStudio employs normalized intensity clustering to automate diploid and polyploid calls, generating quality metrics like Log R ratios. In next-generation sequencing (NGS), the Genome Analysis Toolkit (GATK) HaplotypeCaller uses local assembly and Bayesian genotype likelihoods to call SNPs and indels simultaneously from aligned reads. HISAT-genotype provides a graph-based alignment platform for targeted regions, applying expectation-maximization to infer maximum-likelihood s from haplotype-resolved assemblies. Common parameters ensure reliability, including minimum call rates exceeding 95% per SNP to filter low-confidence loci and Phred quality scores above 20, corresponding to a 1% base-calling error rate. No-calls arise from ambiguous signals, such as overlapping clusters or low coverage, and are managed via probabilistic thresholds to prioritize accuracy over completeness. For example, methods like declare no-calls when posterior probabilities fall below 0.80, modeling raw intensities as t-distributions to quantify uncertainty and flag potential assay failures. Advances incorporate to refine calls in error-prone datasets; neural networks, such as Cluster Buster (2024), train on raw intensities to recover no-calls with high concordance (>99%) to , particularly for ancestry-diverse cohorts in disease studies. These approaches reduce manual intervention while adapting to batch effects and .

Error Detection and Validation

Error sources in SNP genotyping primarily arise from technical limitations in sample preparation and amplification processes. Allelic dropout, where one allele fails to amplify during PCR, is a common issue in low-quality or degraded DNA samples, leading to false homozygous calls. Preferential amplification occurs when one allele is amplified more efficiently than the other due to sequence variations or primer mismatches, resulting in allelic imbalance. Contamination from exogenous DNA can introduce false alleles, particularly in high-throughput workflows. In modern SNP genotyping methods, such as array-based or next-generation sequencing approaches, overall error rates are typically below 0.1%, reflecting improvements in assay design and quality controls. Quality metrics are essential for assessing the reliability of genotypes. Concordance rates between duplicate samples, where at least 99% agreement is expected, serve as a direct measure of and help identify systematic errors. Deviations from Hardy-Weinberg equilibrium (HWE), tested using statistics, indicate potential genotyping issues, as SNPs in a randomly population should conform to expected frequencies based on frequencies. For instance, a test compares observed versus expected counts, with p-values below 0.001 often flagging problematic loci for further investigation. Validation strategies ensure the accuracy of SNP calls beyond initial quality checks. is routinely used to confirm variants, particularly those with low coverage or ambiguous calls, achieving near 100% concordance with high-quality next-generation sequencing data. Internal controls, such as known SNPs with established genotypes, are incorporated into assays to monitor performance and detect batch-specific errors. In family-based studies, Mendelian inconsistencies—where offspring genotypes cannot be derived from parental alleles—are checked in trios to identify errors, with rates exceeding 1% prompting re-genotyping. In forensic applications, protocols emphasize duplicate testing and error tracking to maintain evidential integrity, building on established frameworks for genetic markers.

References

  1. [1]
    Genotype and SNP calling from next-generation sequencing data
    SNP calling identifies variable sites, while genotype calling determines the genotype for each individual at each site.
  2. [2]
    What are single nucleotide polymorphisms (SNPs)? - MedlinePlus
    Mar 22, 2022 · SNPs are the most common genetic variation, representing a difference in a single DNA building block, occurring normally in a person's DNA.
  3. [3]
    The Use of SNPs in Pharmacogenomics Studies - PMC - NIH
    Single Nucleotide Polymorphisms (SNPs) holds the key in defining the risk of an individual's susceptibility to various illnesses and response to drugs. There is ...
  4. [4]
    Overview of Genotyping Technologies and Methods
    ### Overview of Genotyping Technologies: Focus on SNP Genotyping Methods
  5. [5]
    A consolidated catalogue and graphical annotation of dbSNP ... - NIH
    SNPs are conventionally defined as common variations at a single nucleotide position in the genome such that the least common allele is present in at least 1% ...Missing: evolutionary aspects
  6. [6]
    SNP bioinformatics: a comprehensive review of resources - PMC
    Identifiers known as reference SNP identifiers (SNPids), or rsIDs, exist in dbSNP and partially address the issue of unique identifiers, also including ...
  7. [7]
    Single nucleotide polymorphisms and cancer susceptibility - NIH
    SNPs in exons are classified as non-synonymous and synonymous coding SNPs (cSNPs) based on their ability to replace the encoded amino acid. Exonal SNPs ...Exonal Snps And Cancer... · Intronal Snps And Cancer... · Utr-Related Snps And Cancer...
  8. [8]
    The distribution of SNPs in human gene regulatory regions - PMC
    For 34,858 promoter SNPs mapped to 13,723 promoter regions, 2,078 (5.9%) of them are located in the predicted transcription factor binding sites, and 1,969 (5.6 ...
  9. [9]
    Genetic Variation in Coding Regions Between and Within ... - NIH
    Generally, SNP frequencies are found to be higher in noncoding sequences compared to coding sequences. The difference in our set might be due to the method ...
  10. [10]
    Integrating common and rare genetic variation in diverse human ...
    To inform the design and interpretation of such studies, we genotyped 1.6 million common single nucleotide polymorphisms (SNPs) in 1,184 reference individuals ...<|control11|><|separator|>
  11. [11]
    A global reference for human genetic variation | Nature
    Sep 30, 2015 · We characterized a broad spectrum of genetic variation, in total over 88 million variants (84.7 million single nucleotide polymorphisms (SNPs), ...
  12. [12]
    Selecting SNPs to Identify Ancestry - PMC - PubMed Central
    An individual's genotypes at a group of Single Nucleotide Polymorphisms (SNPs) can be used to predict that individual's ethnicity, or ancestry.
  13. [13]
    Common Single Nucleotide Polymorphisms in TCF7L2 Are ...
    Oct 1, 2006 · Recently, common noncoding variants in the TCF7L2 gene were strongly associated with increased risk of type 2 diabetes in samples from ...
  14. [14]
    Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
    Dec 30, 2004 · CYP2D6 genotyping showed that the patient had three or more functional alleles, a finding consistent with ultrarapid metabolism of codeine. We ...Missing: association paper
  15. [15]
    PCA-Correlated SNPs for Structure Identification in Worldwide ...
    Existing methods to ascertain small sets of markers for the identification of human population structure require prior knowledge of individual ancestry.
  16. [16]
    Large-scale SNP analysis reveals clustered and continuous patterns ...
    Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variation. Mark D Shriver
  17. [17]
    SNP Markers and Their Impact on Plant Breeding - PMC - NIH
    This paper provides a review of historical and current efforts in the development, validation, and application of SNP markers in QTL/gene discovery and plant ...
  18. [18]
    SNP Genotyping and Analysis Market Size to Exceed USD 120.03 ...
    Sep 20, 2025 · The SNP Genotyping and Analysis Market, estimated at USD 30.01 Bn in 2025, is expected to exhibit a CAGR of 21.9% and reach USD 120.03 Bn by ...
  19. [19]
    SNP Genotyping by Fragment Analysis | Thermo Fisher Scientific - ES
    DNA extraction is a critical first step in the experimental workflow of DNA Sequencing and Fragment analysis. The overall quality, accuracy and length of the ...
  20. [20]
    Overview of Genotyping Technologies and Methods - Kockum - 2023
    Apr 7, 2023 · This overview covers key concepts in genetics, the development of common genotyping methods, and a comparison of several techniques, including PCR, microarrays ...
  21. [21]
    Sources of Pre-Analytical Variations in Yield of DNA Extracted from ...
    We show that the largest significant variations in DNA yield were observed with degree of haemolysis and with center of subject recruitment.
  22. [22]
    Automated phenol-chloroform extraction of high molecular weight ...
    It has a moderate to high gDNA extraction yield. However, Phenol-Chloroform DNA extraction recovers HMW gDNA due to minimum mechanical shearing in the protocol.
  23. [23]
    Phenol Chloroform DNA Extraction Optimized for HMW gDNA from ...
    Apr 1, 2022 · This protocol details a phenol chloroform DNA extraction optimized to obtain high yields of unfragmented genomic DNA from Coccidioides spp.
  24. [24]
    DNeasy Blood & Tissue Kits | DNA Purification | QIAGEN
    $$40 delivery 30-day returnsDNeasy Blood & Tissue Kits quickly extract DNA using a silica-based, phenol- and chloroform-free process in spin-column and 96-well-plate formats.
  25. [25]
    QIAamp DNA Kits | Genomic DNA Isolation - QIAGEN
    $$40 delivery 30-day returnsQIAamp DNA Kits provide silica-membrane-based nucleic acid purification from tissues, swabs, CSF, blood, body fluids or washed cells from urine.
  26. [26]
    https://www.qiagen.com/us/products/discovery-and-translational-research/dna-rna-purification/dna-purification/genomic-dna/qiaamp-dna-kits
  27. [27]
    Bio-On-Magnetic-Beads (BOMB): Open platform for high-throughput ...
    Jan 10, 2019 · This Community Page article presents open-source nucleic acid purification and handling protocols based on functionalised magnetic beads.
  28. [28]
    KASP Genotyping Services FAQs - LGC, Biosearch Technologies
    + What is the expected yield of DNA from blood samples? We would expect to obtain around 20-30 µg of DNA per 1 mL of human whole blood from a healthy individual ...
  29. [29]
    Fast and inexpensive protocols for consistent extraction of high ...
    Oct 18, 2018 · We consistently obtained good yields of high purity DNA or RNA in all species tested. The protocol has been validated for thousands of DNA samples.
  30. [30]
    DNA sample QC for NGS - QIAGEN
    Pure DNA has an A260/ A280 ratio of 1.7–1.9. Note: For accurate A260 /A280 values, measure absorbance in slightly alkaline buffer (e.g., 10 mM Tris•Cl, pH 7.5) ...Missing: A260/ A280 genotyping
  31. [31]
    Optimization of conditions to extract high quality DNA for PCR ...
    A260/A280 ratio is an indicator for level of protein contamination and for pure DNA it is 1.8. The average A260/A280 ratio was 1.81 ± 0.05 (Table 1). A260/A230 ...
  32. [32]
    Feasibility of extracting usable DNA from blood samples stored up to ...
    Jul 15, 2025 · The DNA concentration ranged from 1.5 to 316.1 ng/μL, with a median value of 68.7 ng/μL, and 981 (96.9%) samples had an acceptable concentration ...
  33. [33]
    KingFisher Flex System | Thermo Fisher Scientific - ES
    The Thermo Scientific KingFisher Flex is a versatile benchtop automated extraction instrument in the lab for 24 or 96 samples per run.
  34. [34]
    Automated DNA and RNA Extraction with KingFisher
    KingFisher automated purification instruments paired with our nucleic acid extraction kits offer fast and precise high-throughput automated extraction.
  35. [35]
    PCR-based single nucleotide polymorphism (SNP) genotyping for ...
    Jun 2, 2025 · This paper reviews the various PCR-based techniques used in SNP genotyping, including allele-specific PCR, real-time PCR, and high-resolution melting analysis.
  36. [36]
    Polymerase Chain Reaction (PCR) - StatPearls - NCBI Bookshelf - NIH
    Jul 7, 2025 · This process is repeated using a thermal cycler, a device that regulates the temperature and duration of each step in the cycle. Repeated ...Missing: genotyping | Show results with:genotyping
  37. [37]
    qPCR Protocol for SNP Genotyping - Thermo Fisher Scientific
    The following protocol uses TaqMan® probes in a SNP genotyping assay on ABI real-time instruments or a standard thermal cycler. Note the separate cycling ...
  38. [38]
    BioInformatics - PCR Efficiency in real-time PCR - Gene-Quantification
    The data indicate that the real-time PCR method is highly efficient with an efficiency coefficient close to the theoretical value of two. The results also show ...
  39. [39]
    Designing Allele-Specific Competitive-Extension PCR-Based ...
    Feb 28, 2022 · We developed a bioinformatic tool for designing probe sequences for PCR-based genotyping assays. Probe sequences are designed in both directions.
  40. [40]
    Real-Time PCR: Revolutionizing Detection and Expression Analysis ...
    Real-time PCR, hereafter abbreviated RT PCR, is becoming a common tool for detecting and quantifying expression profiles of selected genes.
  41. [41]
    Genotyping and quantification techniques for single-nucleotide ...
    The allele-specific hybridization-based SNP genotyping and quantification techniques rely on the detection of the subtle difference in stability caused by a ...
  42. [42]
    Optimizing the specificity of nucleic acid hybridization - PMC - NIH
    Jan 22, 2012 · A hybridization reaction or probe is specific when there is a large difference between the hybridization yield of an intended target X and that ...
  43. [43]
    Robust and Accurate Single Nucleotide Polymorphism Genotyping ...
    We recently introduced a generic single nucleotide polymorphism (SNP) genotyping method, termed DASH (dynamic allele-specific hybridization).
  44. [44]
    Robust and accurate single nucleotide polymorphism genotyping by ...
    We recently introduced a generic single nucleotide polymorphism (SNP) genotyping method, termed DASH (dynamic allele-specific hybridization).
  45. [45]
    Optimizing comparative genomic hybridization probes for ...
    Probe length, melting temperature, GC content, SNP location in the probe, mutation type, and hairpin structures affected SNP sensitivity.
  46. [46]
    iFRET: An Improved Fluorescence System for DNA-Melting Analysis
    The SNP genotyping technique dynamic allele specific hybridization (DASH) was used as a platform to compare iFRET to two alternative fluorescence strategies, ...
  47. [47]
    Discrimination of Single-Nucleotide Polymorphisms in Human DNA ...
    We present here an approach to SNP discrimination based on high-specificity hybridization of peptide nucleic acid (PNA) probes to PCR-amplified DNA.
  48. [48]
    Molecular Beacons: Probes that Fluoresce upon Hybridization - Nature
    Mar 1, 1996 · Molecular Beacons: Probes that Fluoresce upon Hybridization. Sanjay Tyagi &; Fred Russell Kramer. Nature Biotechnology volume 14, pages 303– ...Missing: URL | Show results with:URL
  49. [49]
    [PDF] New frontiers of molecular beacons - DTU Research Database
    reduce the quenching efficiency. [11]. The quenching efficiency in molecular beacons usually lies in between. 85-97% even though recent development have ...
  50. [50]
    (PDF) Genotyping SNPs with molecular beacons - ResearchGate
    Aug 10, 2025 · Oxford, UK. 3. Tyagi, S. and Kramer, F. R. (1996) Molecular beacons: probes that. fluoresce upon hybridization. Nat ...Missing: paper | Show results with:paper
  51. [51]
    Molecular Beacons: A Novel Optical Diagnostic Tool - PMC - NIH
    Molecular beacon assay is one type of RT-PCR technology capable of fast, specific, sensitive, and reliable viral detection.
  52. [52]
    Single nucleotide polymorphism arrays: a decade of biological ...
    Jul 1, 2009 · Commercial probe-based SNP array platforms can now genotype, with >99% accuracy, about one million SNPs in an individual in one assay (12,13).
  53. [53]
    Large-scale genotyping of complex DNA - PubMed
    Large-scale genotyping of complex DNA. Nat Biotechnol. 2003 Oct;21(10):1233-7. doi: 10.1038/nbt869. Epub 2003 Sep 7. Authors. Giulia C Kennedy ... 1 Affymetrix ...
  54. [54]
    Effect of single nucleotide polymorphisms on Affymetrix® match ...
    Jul 14, 2008 · Affymetrix® GeneChip™ platforms historically pair each 25-base perfect match (PM) probe with a mismatch probe (MM) differing by a complementary ...
  55. [55]
    A genome-wide scalable SNP genotyping assay using microarray technology - Nature Genetics
    ### Summary of Illumina Infinium Assay for SNP Genotyping
  56. [56]
    Infinium Assay for Large-scale SNP Genotyping Applications - NIH
    Nov 19, 2013 · Illumina's panel of genotyping BeadChips allows investigators to genotype thousands or millions of single nucleotide polymorphisms (SNPs) or to ...
  57. [57]
    Normalization of Illumina Infinium whole-genome SNP data ...
    Oct 2, 2008 · Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios. Johan Staaf,; Johan ...
  58. [58]
    5.2 - High Density (Affymetrix@) Microarrays and their Normalization
    A PM (perfect match) probe matches to the annotated reference at the time the array was created. The corresponding MM (mismatch) probe differs from the PM by a ...
  59. [59]
    A 25-year odyssey of genomic technology advances and structural ...
    While now less than a few hundred dollars per sample, even cheaper technologies like molecular inversion probes allow the targeting of a modest number of genes ...
  60. [60]
    Forensic investigative genetic genealogy: expanding pedigree ...
    Although more costly—microarray typing ranges from approximately $100 to a few hundred dollars per sample, compared to over $1000 for WGS—the cost of NGS ...
  61. [61]
    Restriction Fragment Length Polymorphism (RFLP) - NCBI - NIH
    Nov 9, 2017 · RFLP is a difference in homologous DNA sequences that can be detected by the presence of fragments of different lengths after digestion of the DNA samples in ...
  62. [62]
    Restriction Fragment Length Polymorphism (RFLP) - Microbe Notes
    Jul 17, 2022 · The basic technique of identifying such restriction fragment length polymorphisms involve fragmenting a sample of DNA by a restriction enzyme, ...
  63. [63]
    An efficient procedure for genotyping single nucleotide polymorphisms
    A simple and economical SNP genotyping method involving a single PCR reaction followed by gel electrophoresis is reported here.
  64. [64]
    Variable fragment length allele-specific polymerase chain reaction ...
    KASP uses fluorescent discrimination of alleles (FRET) for which different dyes and specific detection systems are needed. Other common SNP genotyping methods, ...
  65. [65]
    Construction of a genetic linkage map in man using restriction ...
    We describe a new basis for the construction of a genetic linkage map of the human genome. The basic principle of the mapping scheme is to develop, ...
  66. [66]
    Analysis of any point mutation in DNA. The amplification refractory ...
    Apr 11, 1989 · We demonstrate a system, ARMS (Amplification Refractory Mutation System), that allows genotyping solely by inspection of reaction mixtures after agarose gel ...Missing: original paper
  67. [67]
    PIRA PCR designer for restriction analysis of single nucleotide ...
    Primer-introduced restriction analysis (PIRA-PCR) is widely used to detect Single Nucleotide Polymorphisms (SNPs). To create artificial Restriction Fragment ...Missing: genotyping induced
  68. [68]
    High-Throughput SNP Genotyping by Allele-Specific PCR with ... - NIH
    The technique involves PCR amplification of genomic DNA with two tailed allele-specific primers that introduce priming sites for universal energy-transfer- ...
  69. [69]
    Allele-Specific Quantitative PCR for Accurate, Rapid, and Cost ... - NIH
    We developed a one-step open-source genotyping method based on quantitative PCR. The allele-specific qPCR (ASQ) does not require post-PCR processing.
  70. [70]
    PCR-based SNP genotyping: A comprehensive comparison of ...
    Jun 8, 2025 · This study compared five PCR-based methods for detecting a challenging T-to-A SNP, rs9939609: ARMS-PCR, PIRA-PCR, TaqMan qPCR, CADMA with HRM, and HRM,
  71. [71]
    https://www.sciencedirect.com/science/article/abs/pii/S0003267025003885
  72. [72]
    https://doi.org/10.1073/pnas.140225597
  73. [73]
    The Invader® assay for SNP genotyping - PMC - NIH
    The Invader assay uses a structure-specific flap endonuclease (FEN) to cleave a three-dimensional complex formed by hybridization of allele-specific ...Missing: seminal | Show results with:seminal
  74. [74]
    From gels to chips: “Minisequencing” primer extension for analysis of point mutations and single nucleotide polymorphisms
    ### Summary of Minisequencing Primer Extension Method for SNP Analysis
  75. [75]
    [PDF] SNaPshot Multiplex System for SNP genotyping
    The ability to use unlabeled, user-defined primers allows researchers to incorporate SNPs of interest cost- effectively. The Applied Biosystems™. SNaPshot™ ...Missing: advantages seminal paper
  76. [76]
    Practical genotyping by single-nucleotide primer extension - PMC
    The adapted SNuPE assay is a viable practical alternative for the application space of genotyping large numbers of samples and few SNP or indel variants.Missing: SNaPshot seminal
  77. [77]
    A SNaPshot of next generation sequencing for forensic SNP analysis
    NGS, using Ion Torrent, can genotype 136 SNPs with 97% accuracy, showing potential for forensic analysis, and can genotype hundreds of SNPs.Missing: paper | Show results with:paper
  78. [78]
    Multiplex Snapshot Minisequencing for the Detection of Common ...
    This study uses a multiplex SNaPshot minisequencing assay to detect 10 PAH gene mutations in PKU patients, achieving 100% detection rate in Iranian population.Missing: paper | Show results with:paper
  79. [79]
    Genotyping of Single Nucleotide Polymorphisms by 5′ Nuclease ...
    Single nucleotide polymorphisms (SNPs) are the most common form of human genetic variation (1–8). SNPs are biallelic and occur approximately every 1,000 base ...
  80. [80]
    Allelic discrimination using fluorogenic probes and the 5' nuclease ...
    The 5' nuclease assay has been successfully used to discriminate alleles that differ by a single base substitution. Guidelines have been developed so that an ...
  81. [81]
    SNP Genotyping Analysis Using TaqMan Assays
    TaqMan 5'-nuclease assay chemistry provides a fast and simple way to get single nucleotide polymorphism genotyping results. The assay search and ordering ...Missing: nuclease activity seminal paper
  82. [82]
    A Ligase-Mediated Gene Detection Technique - Science
    An assay for the presence of given DNA sequences has been developed, based on the ability of two oligonucleotides to anneal immediately adjacent to each other.
  83. [83]
    Oligonucleotide ligation assay - PubMed
    Oligonucleotide ligation assay. Methods Mol Biol. 2003:212:215-28. doi: 10.1385/1-59259-327-5:215. Authors. Jonas Jarvius , Mats Nilsson, Ulf Landegren ...Missing: original paper
  84. [84]
    L-RCA (ligation-rolling circle amplification): a general method for ...
    We have demonstrated that SNPs can be efficiently detected using the L-RCA method and simple UV detection. The use of short padlock probes (52–60 nt) and a set ...Missing: variants | Show results with:variants
  85. [85]
    Detection of polymorphisms of human DNA by gel electrophoresis ...
    Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2766-70.Missing: seminal paper
  86. [86]
    Single-Strand Conformational Polymorphism Analysis
    The principle of SSCP analysis is based on the fact that single-stranded DNA has a defined conformation. Altered conformation due to a single base change in the ...Missing: limitations seminal
  87. [87]
    Single-strand conformation polymorphism (SSCP) for the analysis of ...
    Aug 9, 2025 · The SSCP protocol can readily detect point mutations for amplicon sizes of up to 450-500 bp, and usually takes 1-2 days to carry out. This user- ...
  88. [88]
    The sensitivity of single-strand conformation polymorphism analysis ...
    We report that SSCP sensitivity varies dramatically with the size of the DNA fragment being analyzed. The optimal size fragment for sensitive base substitution ...Missing: SNP principle protocol limitations improvements papers
  89. [89]
    Single-Strand Conformation Polymorphism Fingerprint Method for ...
    Aug 26, 2021 · The SSCP fingerprint method can detect more than 90% of a single mutation in fragments of less than 200 nucleotides and more than 80% in 300–400 ...
  90. [90]
    (PDF) Single Strand Conformation Polymorphism (SSCP)-A REVIEW
    Apr 1, 2024 · basic principle, procedure, advantages, disadvantages and applications of SSCP in detail. Key words- Polymorphism, Electrophoresis, PCR,. SNPs, ...
  91. [91]
    Single Strand Conformation Polymorphism - ScienceDirect.com
    PCR-SSCP is highly sensitive and requires a high level of reproducibility with no variation in conditions between analyses (Lockley and Bardsley, 2000). This ...
  92. [92]
    High throughput fluorescent CE-SSCP SNP genotyping - PubMed
    Using PCR with fluorescent labeling and automated capillary electrophoresis SSCP (CE-SSCP), we have developed a panel of 15 functional candidate SNPs. With ...Missing: improvements | Show results with:improvements
  93. [93]
    [PDF] Detection of Single Nucleotide Polymorphisms
    A recent advance in this method is the combined use of fluorescent labels and capillary electrophoresis in SSCP analysis (Inazuka et al., 1997). By labeling ...
  94. [94]
    review SNPs genotyping technologies and their applications in farm ...
    Feb 24, 2014 · The goal of this review is to characterize the SNPs genotyping methods and their applications in farm animals breeding.
  95. [95]
    DNA fragments differing by single base-pair substitutions ... - PNAS
    DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. S G Fischer and L S ...
  96. [96]
    Temperature-gradient gel electrophoresis. Thermodynamic analysis ...
    Temperature-gradient gel electrophoresis. Thermodynamic analysis of nucleic acids and proteins in purified form and in cellular extracts.Missing: Reitz MS
  97. [97]
    Denaturing High Performance Liquid Chromatography - an overview
    Denaturing high-performance liquid chromatography (DHPLC) is a method that detects polymorphisms using the differential elution time of DNA homoduplexes and ...
  98. [98]
    Denaturing high performance liquid chromatography
    DHPLC is a high throughput, sensitive, specific, and robust platform for the detection of DNA variants, such as disease causing mutations or SNPs.Missing: principle protocol
  99. [99]
    Denaturing High-Performance Liquid Chromatography for Mutation ...
    This chapter describes the methods used for mutation detection analysis and the genotyping of SNPs by DHPLC on the WAVE™ system from Transgenomic Inc. (“WAVE ...Missing: principle | Show results with:principle
  100. [100]
    Denaturing high-performance liquid chromatography: A review
    Denaturing high-performance liquid chromatography (DHPLC) compares two or more chromosomes as a mixture of denatured and reannealed PCR amplicons.
  101. [101]
    https://pubmed.ncbi.nlm.nih.gov/11385705/
  102. [102]
    Principle of HRM Technology - QIAGEN
    SYBR Green I versus EvaGreen dye. Saturating intercalating dyes such as EvaGreen are better suited to HRM analysis than nonsaturating intercalating dyes such as ...
  103. [103]
    [PDF] A Guide to High Resolution Melting (HRM) Analysis
    High resolution melting (HRM) analysis is a new, post-PCR analysis method used for identifying genetic variation in nucleic acid sequences.
  104. [104]
    Genotyping of single-nucleotide polymorphisms by high-resolution ...
    Conclusions: SNP genotyping by high-resolution melting analysis is simple, rapid, and inexpensive, requiring only PCR, a DNA dye, and melting instrumentation.Missing: seminal paper
  105. [105]
    What is High Resolution Melting (HRM)? - Bio-Rad
    HRM analyzes DNA melting curves to detect mutations, methylation, & genotypes. It uses dyes & software for analysis & is suitable for SNP genotyping.Processing Melt Curve Data... · HRM Analysis Software
  106. [106]
    High Resolution Melting (HRM) for High-Throughput Genotyping ...
    Nov 3, 2017 · High resolution melting (HRM) is a convenient method for gene scanning as well as genotyping of individual and multiple single nucleotide polymorphisms (SNPs).
  107. [107]
    Determining the effectiveness of High Resolution Melting analysis ...
    Feb 17, 2009 · We compared the capacity of HRM, applicable to both genotyping and mutation scanning, to detect genetic variations in the tumor suppressor gene TP53.
  108. [108]
    (PDF) CADMA and Allele Specific qPCR Techniques Outperforms ...
    Oct 20, 2019 · This study compared five PCR-based methods for detecting a challenging T-to-A SNP, rs9939609: ARMS-PCR, PIRA-PCR, TaqMan qPCR, CADMA with HRM, ...
  109. [109]
    Genotyping SNPs and Indels: A method to improve the scope and ...
    Aug 15, 2024 · Using HRM-qPCR assays based on the modified CADMA method, genotyping of various SNPs was successfully carried out. For some SNPs, similarly ...
  110. [110]
    Genotyping SNPs and Indels: A method to improve the scope and ...
    Aug 15, 2024 · Using HRM-qPCR assays based on the modified CADMA method, genotyping of various SNPs was successfully carried out. For some SNPs, similarly ...Genotyping Snps And Indels... · Abstract · Introduction
  111. [111]
    MALDI mass spectrometry analysis of single nucleotide ...
    The principle of this reaction is applied to genotyping of SNPs by MALDI‐MS. The entire procedure requires only a single tube or well into which reagents are ...
  112. [112]
    A novel MALDI–TOF based methodology for genotyping single ... - NIH
    A new MALDI–TOF based detection assay was developed for analysis of single nucleotide polymorphisms (SNPs). It is a significant modification on the classic ...
  113. [113]
    MALDI-TOF Mass Spectrometry-Based SNP Genotyping
    Principle of MALDI-TOF mass spectrometry. Fig. 1. · The MassEXTEND reaction. Fig. 2. · A. Fig. 3 · Multiplexed MassEXTEND assays. Fig. 4.
  114. [114]
    SNP genotyping using the Sequenom MassARRAY iPLEX platform
    The method for SNP genotyping described in this unit is based on the commercially available Sequenom MassARRAY platform.Missing: multiplexing accuracy applications
  115. [115]
    SNP Genotyping Using the Sequenom MassARRAY iPLEX Platform
    The method for SNP genotyping described in this unit is based on the commercially available Sequenom MassARRAY platform and uses MALDI‐TOF mass spectrometry ...Missing: applications | Show results with:applications
  116. [116]
    https://www.semanticscholar.org/paper/SNP-Genotyping-Using-the-Sequenom-MassARRAY-iPLEX-Gabriel-Ziaugra/7f10da8df046c600b23f583ef14b0832d8f82a98
  117. [117]
    Pharmacogenomics: A Genetic Approach to Drug Development and ...
    The MALDI-TOF detection technique or sequencing can be used to identify the products. It is used as a multiplex reaction for genotyping SNPs. DNA ...Pharmacogenomics: A Genetic... · 2. Pharmacogenomics · 8. Epigenetic Effects And...
  118. [118]
    Genotyping single nucleotide polymorphisms by MALDI mass ...
    This review gives an introduction to the application of mass spectrometry for DNA analysis, and provides an overview of most studies using SNPs as genetic ...
  119. [119]
    Mass spectrometry for genotyping: an emerging tool for molecular ...
    This review outlines some of the most promising genotyping methods developed using electrospray and matrix-assisted laser-desorption-ionization mass ...Missing: papers | Show results with:papers
  120. [120]
    Genotyping single nucleotide polymorphisms using intact ...
    Aug 28, 2001 · In summary, SNPs were genotyped using intact PCR products with ESI quadrupole MS analysis. Sample prep-aration simply involves ethanol ...Missing: amplicons | Show results with:amplicons
  121. [121]
    Error (ACS Publications)
    Insufficient relevant content. The provided URL (https://pubs.acs.org/doi/10.1021/ac000689v) leads to a "Page Not Found" error, indicating the page is inaccessible or does not exist. No information on tandem MS (MS/MS) using ESI for SNP genotyping, including fragmentation patterns, SNP composition determination, protocol steps, or advantages, can be extracted.
  122. [122]
    A primer on current and common sequencing technologies - NCBI
    Sanger sequencing is based on the electrophoretic separation of chain-termination products obtained in individual sequencing reactions. When compared with the ...First Generation Dna... · The Enzymatic Sanger Method · Third Generation Ngs...
  123. [123]
    Mastering DNA chromatogram analysis in Sanger sequencing ... - NIH
    Nov 13, 2023 · Sanger dideoxy sequencing is vital in clinical analysis due to its accuracy, ability to analyze genetic markers like SNPs and STRs, capability ...
  124. [124]
    Sanger Validation of High-Throughput Sequencing in Genetic ... - NIH
    Dec 2, 2020 · Therefore, Sanger sequencing is still considered the gold standard for the validation of NGS genetic variants and an essential step in the ...
  125. [125]
    https://www.sciencedirect.com/science/article/pii/S1872497314002253
  126. [126]
    Next-Generation Sequencing Technology: Current Trends and ... - NIH
    The second generation introduced massively parallel sequencing with platforms such as Illumina and Ion Torrent, enabling high-throughput sequencing. The ...
  127. [127]
    Advancements in Next-Generation Sequencing - Annual Reviews
    Aug 31, 2016 · A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC ...
  128. [128]
    Best practices for variant calling in clinical sequencing - PMC - NIH
    Oct 26, 2020 · The accuracy of NGS variant calls relative to the previous “gold standard” of Sanger sequencing has been well documented at > 99% [77–79].Snv/indel Calling · Identifying De Novo... · Copy Number And Structural...
  129. [129]
    A tale of three next generation sequencing platforms: comparison of ...
    Jul 24, 2012 · We observed error rates of below 0.4% for the Illumina platforms, 1.78% for Ion Torrent and 13% for PacBio sequencing (Table 1). The number of ...
  130. [130]
    Performance Comparison of Illumina and Ion Torrent Next ...
    It is well documented that data from the Ion Torrent platform exhibit a higher rate of sequencing errors than data from the Illumina platform (7–9), and our ...
  131. [131]
    Library construction for next-generation sequencing: Overviews and ...
    Here, we examine the critical role of sequencing library quality and consider important challenges when preparing NGS libraries from DNA and RNA sources.
  132. [132]
    NGS Workflow Steps | Illumina sequencing workflow
    Preparing for the NGS workflow · Step 1: Nucleic acid extraction · Step 2: Library preparation · Step 3: Sequencing · Step 4: Data analysis and interpretation.Missing: SNP amplification
  133. [133]
    Library Preparation Strategies for Next Generation Sequencing
    NGS library preparation is the foundation of sequencing success. Learn how to optimize fragmentation, ligation, and QC for Illumina and Nanopore workflows.
  134. [134]
    Performance evaluation of pipelines for mapping, variant calling and ...
    Apr 28, 2021 · In this study we carried out a comprehensive comparison of the performance of short-read sequence alignment (BWA-MEM, Bowtie2, Stampy) and ...<|control11|><|separator|>
  135. [135]
    Systematic benchmark of state-of-the-art variant calling pipelines ...
    Feb 22, 2022 · GATK-HC combined with the 2D CNN variant filtering showed the worst performance in SNP calling irrespective of the aligner used.
  136. [136]
    Comparison of seven SNP calling pipelines for the next-generation ...
    Bcftools-multiple had the highest sensitivity numerically when the input ranged from 5X to 30X, and 16GT showed the highest sensitivity when the input was 40X ...
  137. [137]
    Comparison of calling pipelines for whole genome sequencing
    Dec 13, 2022 · The DRAGEN mapper and aligner had higher accuracy than the GATK with BWA-MEM2 mapper and aligner. DeepVariant and DRAGEN performed similarly for ...Results · Variant Calling Pipelines · Genome Regions For...
  138. [138]
    Reduced-Cost Genotyping by Resequencing in Peanut Breeding ...
    Oct 24, 2024 · The results indicated that genotyping by a targeted resequencing approach reduced the cost from around USD 28 (SNP chip and GBS) to USD 18 per sample.2. Materials And Methods · 2.1. Target Selection · 2.1. 1. Snp Chip DataMissing: dollars | Show results with:dollars<|separator|>
  139. [139]
    Characterizing and measuring bias in sequence data - PMC
    Bias in sequence data includes coverage bias, a deviation from uniform read distribution, and error bias, a deviation from uniform mismatch, insertion, and ...
  140. [140]
    Genomic diversity affects the accuracy of bacterial single-nucleotide ...
    Genomic diversity negatively impacts SNP calling accuracy, especially with divergent reference genomes, and is more pronounced in diverse bacteria.Genomic Diversity Affects... · Results · Reference Genome Selection...
  141. [141]
    A Robust, Simple Genotyping-by-Sequencing (GBS) Approach for ...
    We report a procedure for constructing GBS libraries based on reducing genome complexity with restriction enzymes (REs). This approach is simple, quick, ...
  142. [142]
    https://www.mdpi.com/2073-4425/15/11/1364
  143. [143]
    Rapid SNP Discovery and Genetic Mapping Using Sequenced RAD ...
    Sequencing of RAD markers is an integrated platform for SNP discovery and genotyping. This approach should be widely applicable to genetic mapping in a variety ...
  144. [144]
    An Inexpensive Method for De Novo SNP Discovery and Genotyping ...
    Double Digest RADseq: An Inexpensive Method for De Novo SNP Discovery and Genotyping in Model and Non-Model Species. Brant K. Peterson, Jesse N. Weber, Emily H.
  145. [145]
    Recent advances in CRISPR-based single-nucleotide fidelity ...
    Jul 1, 2025 · This Review explores recent strategics aimed at refining CRISPRdx specificity for SNV detection including various ways of tactical guide RNA (gRNA) design.
  146. [146]
    Nucleic acid detection with CRISPR-Cas13a/C2c2 - PMC
    Apr 13, 2017 · SHERLOCK can discriminate SNPs for human genotyping and cell-free allele DNA detection. Figure 4. Open in a new tab. (A) Circos plot showing ...Figure 1. Sherlock Is... · Figure 2. Cas13a Detection... · Figure 4. Sherlock Can...Missing: Cas13 seminal
  147. [147]
    CRISPR-Cas12a target binding unleashes indiscriminate single ...
    DETECTR enables rapid and specific detection of human papillomavirus in patient samples, thereby providing a simple platform for molecular diagnostics. CRISPR- ...
  148. [148]
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0037135
  149. [149]
    https://www.nature.com/articles/s43856-025-00933-4
  150. [150]
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5526198/
  151. [151]
    Ultrasensitive and Highly Specific Lateral Flow Assays for Point-of ...
    Feb 19, 2021 · Lateral flow assays (LFAs) are paper-based point-of-care (POC) diagnostic tools that are widely used because of their low cost, ease of use, and rapid format.<|control11|><|separator|>
  152. [152]
    Using mass spectrometry to infer SNP genotypes in pigmented and ...
    Feb 25, 2020 · Proteomic genotyping uses genetically variant peptides that contain single amino acid polymorphisms to infer the genotype of corresponding non-synonymous SNP ...
  153. [153]
    Proteomic genotyping: Using mass spectrometry to infer SNP ...
    Proteomic genotyping is the use of genetically variant peptides (GVPs), detected in a forensic protein sample, to infer the genotype of corresponding non- ...
  154. [154]
    Alternative LC–MS/MS Platforms and Data Acquisition Strategies for ...
    Sep 7, 2021 · Proteomic genotyping is the use of genetically variant peptides (GVPs) that contain single-amino-acid polymorphisms to infer the genotype of ...<|control11|><|separator|>
  155. [155]
    Proteomic Genotyping for Individual Human Identification: Inferring ...
    When viable DNA is absent, proteomic genotyping may be used to associate biological evidence with an individual, similarly to other genetic ...
  156. [156]
    Proteomics in forensics: from source attribution to reconstruction of ...
    Sep 4, 2025 · This literature review, spanning primarily over two decades (2004–2024), traces the steady evolution of proteomics within forensic science ...
  157. [157]
    Preservation of Proteomic and Genomic Genotypes in Skeletal ...
    Oct 30, 2025 · Forensically treated cadavers were analyzed for DNA and protein preservation. · Protein levels were more stable than DNA in all treatments.<|separator|>
  158. [158]
    Mass spectrometry-based proteomics in forensic investigations
    Review; Open access; Published: 16 October 2025. Mass spectrometry-based proteomics in forensic investigations: a focused review of LC-MS applications.
  159. [159]
    Preservation of proteomic and genomic genotypes in skeletal ...
    Skeletal material is often the only remaining evidence in missing persons cases, for mass burials, or disaster victim identification.Missing: review | Show results with:review
  160. [160]
    Smarter clustering methods for SNP genotype calling - PMC - NIH
    In this article, we discuss the impact of incorporating external information into clustering algorithms to call the genotypes for both disomic and trisomic ...Missing: principles | Show results with:principles
  161. [161]
    KRLMM: an adaptive genotype calling method for common and low ...
    May 23, 2014 · A number of algorithms are available for processing the raw signal of paired allele intensities into discrete genotype calls (AA, AB, BB) for ...
  162. [162]
    Bayesian Gaussian Mixture Models for High-Density Genotyping ...
    Abstract. Affymetrix's SNP (single-nucleotide polymorphism) genotyping chips have increased the scope and decreased the cost of gene-mapping studies.
  163. [163]
    Enhanced SNP genotyping with symmetric multinomial logistic ...
    The grey area marks the no-call zone where genotype probabilities fall short of the threshold. 9937 (a value chosen for illustrative purposes). Outside the ...Research Paper · 2. Materials And Methods · 3. Results
  164. [164]
    GenomeStudio Software | Visualize and analyze Illumina array data
    The software uses trusted algorithms to normalize, cluster, and call genotypes. Analyze SNP and CNV data across millions of markers and probes; Estimate Log R ...Missing: GATK | Show results with:GATK
  165. [165]
    HaplotypeCaller - GATK - Broad Institute
    Nov 2, 2021 · The HaplotypeCaller is capable of calling SNPs and indels simultaneously via local de-novo assembly of haplotypes in an active region.
  166. [166]
    HISAT-genotype
    HISAT-genotype is a next-generation genomic analysis software platform capable of assembling and genotyping human genes and genomic regions.Missing: SNP | Show results with:SNP
  167. [167]
    genotype calling algorithm for the Illumina BeadArray platform
    Manual inspection and adjustment of the genotype classifications was performed on all SNPs with: (a) call rates < 95.0% at a GC score cutoff of 0.20; (b) call ...
  168. [168]
    ALCHEMY: a reliable method for automated SNP genotype calling ...
    In practice, a threshold for this probability of correctness is set and all calls which are below this threshold are taken as 'no calls'. This allows a simple ...
  169. [169]
    A Machine Learning Algorithm for Genotyping SNPs from Raw Data
    Aug 26, 2024 · We introduce Cluster Buster, a genotyping neural network and visual inspection system designed to improve the quality of neurodegenerative disease (NDD) ...
  170. [170]
    Evaluating the Impact of Dropout and Genotyping Error on SNP ...
    Jun 30, 2022 · The goal of this study was to evaluate the accuracy of genome-wide relatedness methods and IBD segment approaches in the presence of challenges ...
  171. [171]
    Modified allele-specific PCR improves HER2 Ile655Val detection by ...
    Oct 5, 2017 · The rate of genotyping errors was from 10% to 50% depending on the amount and ratio of DNA template and the annealing temperature of PCR.
  172. [172]
    Noninvasive population assessment of moose (Alces alces) by SNP ...
    Nov 25, 2019 · The SNP error rate of the quality filtered dataset was 0.06 and the probability of identity for siblings below 0.001. Following a thorough ...
  173. [173]
    Quality Control Measures and Validation in Gene Association Studies
    Genotyping was performed in a blinded fashion with approximately 10% of genotyped samples duplicated for QC. SNP QC measures included Hardy-Weinberg equilibrium ...
  174. [174]
    Detection of genotyping errors by Hardy-Weinberg equilibrium testing
    This study has analysed 107,000 genotypes generated by TaqMan, RFLP, sequencing or mass spectrometric methods from 443 single-nucleotide polymorphisms (SNPs).Missing: statistical Chi- square Mendelian inconsistency trios
  175. [175]
    Detection of genotyping errors by Hardy-Weinberg equilibrium testing
    Aug 5, 2025 · Deviation from Hardy-Weinberg equilibrium (HWE) in random samples may be indicative of problematic assays. This study has analysed 107,000 ...
  176. [176]
    Genome-Wide SNP Detection, Validation, and Development of an ...
    GDsnps also provided internal controls for validation of SNPs with the GoldenGate® assay. The series of previously validated GDsnps [7], [11] as a whole ...
  177. [177]
    Detection of Genotyping Errors and Pseudo-SNPs Via Deviations ...
    For trio data, genotyping errors can sometimes be detected by observation of Mendelian inconsistencies; however, the ability to detect Mendelian ...
  178. [178]
    Toward minimal SNP sets for record-matching with CODIS STR ...
    Sep 22, 2025 · Genetic record-matching is a technique by which profiles with one set of genetic markers can be queried against databases of profiles with a ...Missing: Practice | Show results with:Practice
  179. [179]
    Internal quality assessment and genotyping error investigation in ...
    Sep 15, 2025 · Sanger sequencing confirmed the C/T genotype but revealed allelic imbalance, with the T peak roughly three times higher than C. Analysis ...